Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3017766	p-c4	g/l (g/l)	8174	13886	0.24%
3017766	s-c4	g/l (g/l)	6297	10208	0.00%
3017766	p-c4	— (—)	719	964	100.00%	Distribution not available
3017766	s-c4	— (—)	436	589	100.00%	Distribution not available
3017766	s-c4	g/l_______ (g/l)	168	222	0.00%
3017766	s-komplementtic4	g/l_______ (g/l)	72	96	0.00%
3017766	p-c4	G/L (g/l)	16	16	0.00%
3017766	p-c4d	— (—)	10	10	100.00%	Distribution not available
3017766	p-c4	g/l_______ (g/l)	9	10	0.00%	Distribution not available
3017766	s-c4h	g/l (g/l)	7	7	0.00%	Distribution not available
3017766	p-c4d	ug/ml (g/l)	6	6	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Explicit Sepsis, including avohilmo

1594

5113

2.95

320.61

2.0

1.6

0.24

0.23

g/l

1.73

1515

4872

Explicit Sepsis

1559

5010

2.95

315.60

2.0

1.6

0.24

0.23

g/l

1.81

1482

4772

Diseases of the musculoskeletal system and connective tissue

1540

2422

3.28

313.57

2.1

1.2

0.23

0.24

g/l

5.98

1476

2313

Systemic sclerosis, icd10

310

277

16.35

313.36

2.4

1.7

0.20

0.24

g/l

5.76

298

267

Cardiovascular diseases (excluding rheumatic etc)

2190

4974

2.60

311.35

2.2

1.8

0.24

0.22

g/l

15.52

2107

4760

Aplastic and other anaemias

1608

5353

2.87

308.03

1.9

1.6

0.24

g/l

0.43

1519

5091

Neurological diseases, wide definition

856

847

5.25

307.72

2.0

1.2

0.23

g/l

0.57

817

802

Immunodeficiencies

414

544

9.42

307.70

2.2

1.6

0.22

0.24

g/l

2.04

376

517

Adverse effects, not elsewhere classified

1232

2829

4.84

307.65

1.8

1.9

0.24

0.23

g/l

1.81

1132

2711

Oedema, not elsewhere classified

1497

3370

4.64

307.65

1.8

1.6

0.24

0.23

g/l

1.68

1418

3204

L04AA Selective immunosuppressants

1414

3021

5.24

307.65

3.7

1.6

0.22

0.24

g/l

8.60

1371

2873

SLE, ICD10

854

377

60.86

307.65

7.8

1.3

0.18

0.24

g/l

25.99

823

360

Finngen Rheumatological endpoints

4212

6315

3.98

307.65

2.6

1.3

0.22

0.24

g/l

27.68

4046

6016

Headache

2350

6481

2.90

307.65

1.9

1.6

0.23

g/l

0.16

2244

6202

Anaemias

1083

1230

6.03

307.65

2.5

1.9

0.23

0.22

g/l

6.06

1042

1180

Seropositive rheumatoid arthritis

1017

2108

5.13

307.65

2.1

1.2

0.21

0.24

g/l

21.87

976

1995

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3083

7399

2.51

307.65

2.0

1.7

0.24

0.23

g/l

2.12

2943

7071

Systemic sclerosis (FG)

310

161

28.28

307.65

2.4

1.1

0.20

0.24

g/l

3.74

298

151

Asthma, unspecified (mode), excluding more controls

1801

4109

3.26

307.65

1.7

0.24

0.23

g/l

3.25

1736

3926

First line medication for Crohn's disease

5090

6779

4.26

307.65

2.3

1.3

0.23

0.24

g/l

4.43

4865

6483

Condition for Implicit Sepsis (Organ dysfunction codes)

2880

8611

2.39

307.65

1.9

1.7

0.24

0.23

g/l

5.10

2743

8238

Bacterial Sepsis

1867

4676

3.47

307.65

2.0

1.6

0.24

0.23

g/l

2.37

1758

4453

Certain disorders involving the immune mechanism

1045

2474

4.66

307.65

1.9

1.7

0.24

g/l

0.23

985

2365

Tramadol

2660

6681

2.47

307.65

1.8

1.7

0.24

0.23

g/l

5.77

2542

6379

Unspecified kidney failure

551

836

7.31

307.65

1.6

1.5

0.26

0.23

g/l

7.50

532

794

Renal failure

2579

4375

5.46

307.65

1.8

1.6

0.26

0.23

g/l

36.60

2486

4122

Asthma-related infections

2188

8676

2.55

307.65

1.7

1.8

0.24

0.23

g/l

3.57

2096

8264

Oral corticosteroids

5512

7335

4.70

307.65

2.3

1.4

0.23

0.24

g/l

7.06

5251

7001

Other necrotizing vasculopathies (FG)

498

421

14.48

307.65

2.2

1.2

0.24

0.25

g/l

0.28

475

397

Azathioprine

880

1382

7.11

307.65

4.4

1.4

0.21

0.24

g/l

12.86

851

1326

ILD medications: immunosuppressive drugs

4129

6031

6.81

307.65

2.7

1.3

0.22

0.24

g/l

16.31

3973

5749

ILD, hospital admissions 1, main diag only

738

1388

5.93

307.65

1.9

1.5

0.23

0.24

g/l

2.95

715

1321

Pain in limb

2810

7621

2.42

307.65

1.9

1.8

0.24

0.23

g/l

3.49

2690

7272

Malaise and fatigue

1706

4712

2.95

307.65

1.8

1.6

0.24

0.23

g/l

1.01

1623

4490

All kidney diseases

4025

9609

2.93

307.65

2.1

1.7

0.25

0.23

g/l

26.98

3873

9151

Raynaud syndrome

810

1170

8.46

307.65

1.9

0.21

0.23

g/l

12.44

789

1105

All pneumoniae

3417

10472

2.18

307.65

2.0

1.7

0.24

0.23

g/l

1.76

3261

10007

Other joint disorders

2769

6026

2.46

307.65

1.9

1.7

0.23

g/l

2.31

2648

5760

All chronic kidney diseases

2952

5172

4.91

307.65

2.3

1.6

0.25

0.23

g/l

33.06

2849

4910

Polyarthropathies

3119

5269

4.02

307.65

1.9

1.7

0.23

0.24

g/l

1.39

2998

5029

Dermatitis and eczema

3957

10243

2.36

307.65

1.9

1.7

0.23

0.24

g/l

2.28

3781

9781

Implicit Sepsis, including avohilmo

2892

8426

2.54

307.65

1.9

1.7

0.24

0.23

g/l

5.49

2751

8062

Dermatitis

2664

8871

3.09

307.65

1.9

1.7

0.23

0.24

g/l

4.16

2547

8465

Other bacterial diseases, including avohilmo

3573

9534

2.42

307.65

1.9

1.7

0.24

0.23

g/l

9.60

3419

9109

Other soft tissue disorders, not elsewhere classified

3370

7739

2.56

307.65

1.9

1.8

0.24

0.23

g/l

2.08

3233

7387

Renal tubulo-interstitial diseases

3541

9274

2.92

307.65

1.9

1.7

0.25

0.23

g/l

27.22

3403

8837

Other bacterial diseases

3349

9165

2.50

307.65

1.9

1.7

0.24

0.23

g/l

7.52

3196

8755

Interstitial lung disease endpoints

807

1572

5.68

307.65

1.9

1.5

0.23

0.24

g/l

3.05

781

1496

Influenza and pneumonia

3567

10331

2.19

307.65

2.0

1.7

0.24

0.23

g/l

1.20

3405

9875

Autoimmune diseases

4136

6919

3.15

307.65

2.2

1.3

0.23

0.24

g/l

15.91

3964

6611

Autoimmune diseases excluding thyroid diseases

4772

6863

3.97

307.65

2.4

1.3

0.22

0.24

g/l

25.36

4572

6558

Arthropathies

2866

6048

2.46

307.65

1.9

1.7

0.23

g/l

1.42

2748

5782

Bacterial infection, other or unspecified

2064

5582

3.27

307.65

1.9

1.6

0.25

0.23

g/l

6.44

1953

5313

Asthma (only as main-diagnosis), excluding more controls

2444

4324

3.24

307.65

1.7

0.24

0.23

g/l

3.15

2347

4132

Systemic connective tissue disorders

3847

3848

12.43

307.65

3.2

1.2

0.21

0.24

g/l

62.68

3713

3634

Asthma, excluding more controls

2566

4324

3.16

307.65

1.7

0.24

0.23

g/l

3.40

2467

4132

Used for control exclusion in common control thyroid runs

3728

6356

3.06

307.65

2.2

1.3

0.23

0.24

g/l

14.28

3575

6074

Urticaria

1524

4476

3.66

307.65

1.9

0.23

g/l

0.21

1435

4292

Other systemic involvement of connective tissue (FG)

2666

2248

14.23

307.65

2.8

1.2

0.21

0.24

g/l

45.48

2578

2128

Reimbursement for rheumatic diseases

3646

7464

5.35

307.65

3.0

1.4

0.21

0.24

g/l

54.44

3516

7100

Asthma, unspecified (mode)

1825

4389

3.11

307.65

1.7

0.24

0.23

g/l

2.90

1758

4196

Other disorders of skin and subcutaneous tissue

2779

9050

2.70

307.65

2.2

1.6

0.23

0.24

g/l

1.87

2643

8635

Second line medication for Crohn's disease

3284

8177

4.35

307.65

2.7

1.5

0.22

0.24

g/l

23.37

3163

7799

Other arthritis (FG)

1561

2999

5.63

307.65

1.9

1.3

0.23

0.24

g/l

4.74

1505

2856

3083

7399

2.51

307.65

2.0

1.7

0.24

0.23

g/l

2.12

2943

7071

Dialysis, with operation codes

805

1231

7.48

307.65

1.9

1.6

0.26

0.23

g/l

9.01

768

1168

Coagulation defects, purpura and other haemorrhagic conditions

993

2561

4.21

307.65

2.7

1.7

0.22

0.23

g/l

6.72

935

2439

Rheumatoid arthritis

1417

3021

4.43

307.65

2.1

1.6

0.22

0.24

g/l

13.06

1357

2876

Pain in joint

2507

4258

3.80

307.65

1.8

1.7

0.23

g/l

0.61

2389

4074

Examination and observation for other reasons

1931

3945

2.85

307.65

1.9

1.6

0.23

0.24

g/l

2.21

1848

3793

Nephropathy related operations

754

1348

6.36

307.65

2.0

1.5

0.26

0.24

g/l

5.69

719

1283

Dyspnoea

3132

10044

2.32

307.65

1.9

1.7

0.24

0.23

g/l

2.68

3007

9577

Glomerular disorders in diseases classified elsewhere

925

1197

9.21

307.65

3.6

1.5

0.26

0.24

g/l

5.60

884

1138

SLE, strict definition

854

377

60.86

307.65

7.8

1.3

0.18

0.24

g/l

25.99

823

360

Rheumatoid arthritis, including avohilmo

1625

5089

3.39

307.65

2.1

1.7

0.22

0.24

g/l

14.91

1556

4818

Abnormalities of breathing

3128

7218

2.56

307.65

1.9

1.7

0.24

0.23

g/l

3.48

2999

6907

General symptoms and signs

3812

6823

2.90

307.65

2.0

1.6

0.23

g/l

0.86

3651

6530

Vasculitis limited to skin, not elsewhere classified

395

261

23.82

307.65

1.9

1.6

0.24

0.23

g/l

0.07

383

252

Other necrotizing vasculopathies

600

621

11.86

307.65

2.8

1.2

0.24

g/l

0.33

575

591

Septicaemia

1471

4496

3.11

307.65

1.9

1.6

0.24

0.23

g/l

2.67

1395

4280

Interstitial lung disease

807

1572

5.68

307.65

1.9

1.5

0.23

0.24

g/l

3.05

781

1496

Other respiratory diseases principally affecting the interstitium

928

1876

5.44

307.65

1.9

1.5

0.23

0.24

g/l

2.10

897

1787

Other interstitial pulmonary diseases

807

1560

5.72

307.65

1.9

1.5

0.23

0.24

g/l

3.02

781

1485

Heart failure, not strict

2672

6374

2.94

307.65

1.9

1.6

0.25

0.23

g/l

8.29

2560

6069

Diseases of the skin and subcutaneous tissue

3057

6227

2.53

307.65

1.9

1.6

0.23

0.24

g/l

0.81

2918

5964

Asthma

2627

4627

3.03

307.65

1.7

0.24

0.23

g/l

3.13

2526

4424

Other specified/unspecified arthritis

1387

2976

5.04

307.65

1.9

1.6

0.23

0.24

g/l

1.37

1338

2841

Asthma (only as main-diagnosis)

2492

4627

3.12

307.65

1.7

0.24

0.23

g/l

2.69

2391

4424

Other and unspecified vasculitis limited to skin

372

228

26.49

307.65

1.9

1.6

0.24

g/l

0.01

361

220

SLE (Finngen)

877

247

89.07

307.65

7.6

1.2

0.18

0.25

g/l

22.84

846

235

Care involving dialysis

542

802

7.85

307.65

2.0

1.6

0.26

0.24

g/l

4.62

522

758

Urticaria and erythema

1827

5499

3.56

307.65

2.0

1.8

0.23

g/l

0.42

1727

5264

Implicit bacterial Sepsis

1649

4101

3.63

307.65

1.9

1.5

0.24

0.23

g/l

2.81

1549

3899

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2326

8136

2.58

307.65

1.8

1.7

0.23

0.24

g/l

1.08

2220

7752

Diseases of arteries, arterioles and capillaries

2285

6374

2.73

307.65

1.7

1.6

0.23

0.24

g/l

1.86

2197

6058

Implicit viral Sepsis, including avohilmo

1225

3698

3.49

307.65

2.2

1.6

0.24

0.23

g/l

1.00

1152

3523

Other specified/unspecified systemic involvement of connective tissue

970

539

29.78

307.65

3.8

1.2

0.20

0.24

g/l

22.85

946

509

L04AX Other immunosuppressants

3227

7920

4.42

307.65

2.7

1.5

0.22

0.24

g/l

23.57

3108

7552

Other and unspecified dermatitis

2388

7544

3.35

307.65

2.0

1.7

0.23

g/l

4.29

2284

7202

Other specific joint derangements/joint disorders

3020

5938

3.31

307.65

1.9

1.7

0.23

g/l

1.63

2877

5675

Systemic lupus erythematosus, unspecified

779

331

70.47

307.65

7.8

1.3

0.18

0.24

g/l

24.16

749

318

Fever of other and unknown origin

2698

5749

4.32

307.65

2.3

1.6

0.24

0.23

g/l

2.63

2582

5494

Other and unspecified urticaria

1029

2745

4.07

307.65

1.9

0.23

g/l

0.96

961

2626

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3315

10485

2.16

307.65

2.0

1.7

0.24

0.23

g/l

1.54

3162

10019

Implicit Sepsis

2748

7723

2.72

307.65

1.9

1.7

0.24

0.23

g/l

4.41

2609

7387

Cutaneous lupus erythematosus

419

244

30.28

307.65

4.3

1.6

0.20

0.24

g/l

7.85

404

232

Other and unspecified effects of external causes

1407

4075

3.71

307.65

1.8

1.9

0.24

0.23

g/l

1.10

1300

3918

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4276

9450

3.20

307.65

2.1

1.6

0.23

0.24

g/l

1.33

4069

9039

ILD, hospital admissions

801

1556

5.70

307.65

1.9

1.5

0.23

0.24

g/l

3.15

775

1481

Implicit bacterial Sepsis, including avohilmo

1800

4477

3.52

307.65

1.9

1.5

0.24

0.23

g/l

3.13

1696

4265

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

505

762

7.62

307.65

2.0

1.4

0.25

0.24

g/l

2.02

480

732

Asthma (mode)

2576

4687

2.99

307.65

1.7

0.24

0.23

g/l

2.99

2476

4483

Pneumonias (Asthma/COPD co-morbidities)

3398

10453

2.18

307.65

2.0

1.7

0.24

0.23

g/l

1.69

3243

9989

Other peripheral vascular diseases

717

911

9.56

307.65

1.9

1.8

0.21

0.23

g/l

8.09

700

864

Other systemic involvement of connective tissue

2712

2967

11.13

307.65

2.8

1.2

0.21

0.24

g/l

50.65

2623

2800

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2981

9121

2.27

307.65

1.9

1.7

0.24

0.23

g/l

5.44

2842

8726

Asthma, hospital admission 2, infections

2188

8676

2.55

307.65

1.7

1.8

0.24

0.23

g/l

3.57

2096

8264

Systemic lupus erythematosus

877

333

65.66

307.65

7.6

1.2

0.18

0.25

g/l

26.56

846

315

Bacterial infection, other or unspecified, including avohilmo

2228

6154

3.10

307.65

1.9

1.6

0.24

0.23

g/l

6.61

2109

5869

ILD medications

5661

6595

4.92

307.65

2.3

1.3

0.23

0.24

g/l

6.14

5421

6289

Glomerulonephritis

706

1069

7.72

307.65

2.9

1.6

0.25

0.23

g/l

3.93

678

1013

Autoimmune diseases excluding thyroid diseases, strict definition

4620

6641

3.98

307.65

2.4

1.3

0.22

0.24

g/l

22.90

4426

6348

Glomerular diseases

1401

2055

7.99

307.65

3.1

1.6

0.25

0.23

g/l

7.93

1344

1957

Autoimmune diseases related-to ILD

4448

9395

4.22

307.65

2.8

1.3

0.22

0.24

g/l

35.80

4274

8938

Chronic kidney disease

1919

2945

6.95

307.65

1.9

1.5

0.26

0.23

g/l

28.35

1853

2775

Pneumonia, organism unspecified

3095

9656

2.26

307.65

1.9

1.7

0.24

0.23

g/l

1.37

2960

9223

Systemic sclerosis

310

214

21.15

307.65

2.4

1.2

0.20

0.25

g/l

7.18

298

203

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

717

300

19.02

307.65

2.0

1.2

0.23

0.24

g/l

1.49

695

278

ILD medications: prednisolone, methylprednisolone, prednisone

5506

6464

5.04

307.65

2.3

1.3

0.23

0.24

g/l

6.63

5267

6161

Sicca syndrome [Sjögren]

1155

831

20.06

307.65

2.8

1.3

0.20

0.24

g/l

31.43

1122

794

ILD, hospital admission 2, with pulmonary infections

557

854

7.30

307.65

1.9

1.4

0.23

0.24

g/l

1.36

535

812

Inflammatory bowel disease treatment related agents

5607

7601

4.34

307.65

2.3

1.4

0.23

0.24

g/l

7.83

5358

7261

Acute renal failure

1206

2134

6.23

307.65

1.9

1.5

0.26

0.23

g/l

15.35

1157

2017

Cardiovascular diseases

2145

4019

2.93

307.65

2.2

1.8

0.23

0.22

g/l

5.93

2063

3845

ILD medications: azathioprine

880

1220

8.07

307.65

4.4

1.3

0.21

0.24

g/l

13.66

851

1168

Infections, IBD-co-morbidities

570

500

8.47

307.65

2.0

1.2

0.23

0.24

g/l

0.70

540

468

Abnormal findings on diagnostic imaging of lung

1645

5793

2.80

304.71

1.8

1.6

0.23

0.24

g/l

1.40

1565

5504

Other septicaemia, including avohilmo

1334

4146

3.15

304.61

1.8

1.6

0.24

0.23

g/l

1.83

1268

3942

Hypertensive diseases (excluding secondary)

1768

3707

2.88

303.73

2.2

1.7

0.25

0.22

g/l

19.32

1702

3539

Other septicaemia

1306

4053

3.17

301.73

1.8

1.6

0.24

0.23

g/l

2.05

1243

3856

1722

6581

2.71

300.65

1.7

1.8

0.24

0.23

g/l

4.04

1654

6271

Other heart diseases

1632

3759

2.93

299.11

2.1

1.7

0.24

0.22

g/l

8.32

1562

3598

Viral Sepsis

881

2341

4.01

291.06

2.3

1.6

0.24

0.23

g/l

1.45

826

2224

Any reimbursement code in KELA

1789

3246

2.84

288.75

2.2

1.4

0.23

g/l

0.06

1709

3111

Implicit viral Sepsis

877

2337

4.00

288.55

2.3

1.6

0.24

0.23

g/l

1.52

823

2220

Pain, not elsewhere classified

1044

3126

3.50

286.53

1.8

1.7

0.24

0.23

g/l

1.30

1005

2985

Other and unspecified anaemias

1470

4990

2.88

286.51

1.9

1.6

0.24

0.23

g/l

0.43

1391

4735

Other anaemias

1478

5023

2.87

285.63

1.9

1.6

0.24

0.23

g/l

0.41

1399

4768

Asthma (diagnoses ohter than nonallergic)

2909

11389

2.12

284.54

1.6

1.8

0.24

0.23

g/l

4.40

2787

10866

Any gastric operation

2331

4896

2.45

283.92

1.9

1.7

0.23

g/l

1.29

2213

4725

GASTRO-related operations

2331

4896

2.45

283.92

1.9

1.7

0.23

g/l

1.29

2213

4725

Certain infectious and parasitic diseases

2892

6725

2.21

279.36

2.0

1.7

0.23

g/l

0.16

2761

6442

L04AD Calcineurin inhibitors

633

1380

5.14

275.99

3.0

1.6

0.24

0.23

g/l

0.49

602

1313

Heart failure and antihypertensive medication

851

1337

4.35

275.34

1.9

1.6

0.24

0.23

g/l

4.82

813

1280

ILD, hospital admissions 3, with pneumonia sepsis

457

741

6.87

274.45

1.9

1.4

0.23

0.24

g/l

1.03

439

707

Pain in throat and chest

2600

7042

2.24

272.89

1.9

1.7

0.23

g/l

0.62

2497

6734

Other diseases of pleura

1470

4715

2.82

270.62

2.0

1.5

0.24

g/l

0.89

1401

4468

Other pulmonary diagnosis

2226

4681

2.44

269.79

1.9

1.7

0.23

g/l

0.44

2129

4477

Excluding asthma or asthma-COPD overlap

2222

4681

2.44

268.28

1.9

1.7

0.23

g/l

0.43

2123

4477

Fibromyalgia

559

1124

5.54

267.48

2.0

1.9

0.23

g/l

0.61

530

1057

Nephrotic syndrome

299

314

12.29

266.36

2.4

1.3

0.26

0.23

g/l

2.92

289

300

Extracorporeal dialysis

412

628

7.70

265.73

2.0

1.5

0.26

0.24

g/l

2.36

393

603

Abnormal findings on examination of blood, without diagnosis

1587

5594

2.67

265.39

1.8

1.6

0.24

g/l

0.75

1515

5337

Symptoms and signs involving the circulatory and respiratory systems

2992

7229

2.12

263.18

2.0

1.7

0.23

g/l

1.17

2865

6917

Secondary hypertension

405

590

7.45

263.07

3.0

1.6

0.25

0.23

g/l

4.55

385

560

COPD differential diagnosis

2210

4689

2.42

262.89

1.9

1.7

0.23

g/l

0.37

2110

4485

ILD differential diagnosis

2209

4687

2.42

262.71

1.9

1.7

0.23

g/l

0.38

2109

4483

Heart failure,strict

1545

4039

2.77

260.85

1.8

1.5

0.24

g/l

1.33

1477

3838

Purpura and other haemorrhagic conditions

682

1643

4.54

260.14

2.6

1.6

0.22

0.24

g/l

6.68

635

1558

Antihypertensive medication - note that there are other indications

1967

4175

2.53

259.31

2.3

1.7

0.23

0.22

g/l

9.68

1894

3994

Opioids

2954

7399

2.11

258.22

1.8

0.24

0.23

g/l

4.70

2816

7074

Ulcer of lower limb, not elsewhere classified

628

1429

4.74

256.52

1.8

1.5

0.25

0.24

g/l

2.58

594

1359

Sulfasalazine

937

2836

3.45

252.56

1.6

1.4

0.22

0.24

g/l

7.00

887

2705

Other disorders of lacrimal gland

1410

5398

2.74

250.77

2.4

1.7

0.22

0.24

g/l

4.97

1355

5121

Codeine

2797

7308

2.12

249.79

1.9

1.8

0.24

0.23

g/l

4.87

2665

6984

Disorders of thyroid, IBD co-morbidities

516

600

6.12

248.38

1.9

1.2

0.23

0.24

g/l

0.86

491

566

Other heart diseases, wide

2894

8710

2.06

247.48

2.0

1.8

0.24

0.23

g/l

1.39

2773

8317

Asthma, hospital admissions , main diagnosis only

2652

11485

2.06

244.75

1.6

1.8

0.24

0.23

g/l

2.65

2543

10952

COPD/asthma/ILD related infections

2980

7399

2.06

244.02

2.0

1.7

0.23

g/l

0.74

2846

7071

COPD/asthma related infections

2980

7399

2.06

244.02

2.0

1.7

0.23

g/l

0.74

2846

7071

Medical observation and evaluation for suspected diseases and conditions

1892

3954

2.51

243.84

2.0

1.6

0.23

0.24

g/l

1.99

1823

3801

Diseases of arteries, arterioles and capillaries (FINNGEN)

796

1425

4.04

240.45

1.7

1.6

0.24

0.23

g/l

2.81

760

1358

Asthma-related pneumonia

1270

4689

2.81

239.75

1.7

0.24

0.23

g/l

2.01

1219

4435

Asthma-related pneumonia or sepsis

1271

4703

2.81

238.89

1.8

1.7

0.24

0.23

g/l

2.00

1220

4448

Asthma, hospital admissions 3, pneumonia

1271

4703

2.81

238.89

1.8

1.7

0.24

0.23

g/l

2.00

1220

4448

Gout

855

2120

3.61

237.55

1.5

0.26

0.24

g/l

9.92

819

2015

Other disorders involving the immune mechanism, not elsewhere classified

296

358

10.50

236.54

2.0

1.5

0.26

0.24

g/l

2.13

280

342

Chronic lower respiratory diseases

3627

10359

1.88

232.73

1.7

1.8

0.24

0.23

g/l

4.14

3473

9884

Enlarged lymph nodes

626

1533

4.34

231.31

2.8

1.7

0.23

g/l

1.22

602

1452

Seropositive rheumatoid arthritis, wide

1016

3450

3.11

227.36

2.1

1.6

0.21

0.24

g/l

14.88

975

3270

Polymyalgia rheumatica

524

1135

4.96

227.23

1.7

1.2

0.24

g/l

0.68

501

1067

Cerebrovascular diseases (FINNGEN)

991

2185

3.31

227.20

2.0

1.7

0.24

0.23

g/l

6.54

950

2086

Hypothyroidism, strict autoimmune

1931

5585

2.32

226.98

1.9

1.3

0.23

0.24

g/l

6.19

1830

5333

Erysipelas, including avohilmo

2119

7298

2.21

226.34

1.7

1.6

0.24

0.23

g/l

7.14

2022

6962

Other diseases of pericardium

290

355

9.45

225.57

2.7

1.5

0.24

g/l

0.02

277

336

3335

8987

1.92

224.99

1.9

1.7

0.24

0.23

g/l

1.23

3180

8587

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

278

334

10.60

223.46

2.0

1.5

0.26

0.24

g/l

3.14

262

320

Low back pain

2397

7892

2.10

221.62

1.8

0.24

0.23

g/l

1.97

2286

7543

Disorders of lacrimal system

1568

6578

2.44

220.01

2.3

1.7

0.22

0.24

g/l

5.25

1508

6255

Other/unspecified seropositive rheumatoid arthritis

996

3415

3.08

219.05

2.1

1.6

0.21

0.24

g/l

14.38

956

3237

Symptoms and signs involving the skin and subcutaneous tissue

2334

10987

2.06

218.30

2.0

1.7

0.23

g/l

2.21

2237

10469

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

985

3375

3.09

216.98

2.0

1.7

0.21

0.24

g/l

13.47

945

3198

Bronchitis

3294

10755

1.88

215.75

2.0

1.7

0.24

0.23

g/l

1.22

3139

10277

Methotrexate

539

1245

4.62

215.33

2.4

1.4

0.21

0.24

g/l

8.25

522

1192

Dorsalgia

2925

8042

1.97

214.39

1.8

0.23

g/l

0.40

2797

7689

Hypertensive diseases

2326

6341

2.12

210.74

2.1

1.7

0.25

0.23

g/l

20.53

2228

6065

Soft tissue disorders

2925

7794

1.96

210.64

1.8

0.23

g/l

1.03

2816

7439

Hypertension

2321

6335

2.12

209.53

2.1

1.7

0.25

0.23

g/l

20.43

2223

6059

Diseases of oesophagus, stomach and duodenum

3161

10133

1.88

208.00

1.9

1.7

0.23

g/l

0.01

3000

9690

Asthma, including avohilmo

3483

10706

1.83

206.18

1.7

1.8

0.24

0.23

g/l

3.34

3338

10214

Heart failure, strict

1643

4946

2.38

205.10

1.8

1.5

0.24

g/l

0.48

1571

4699

Migraine

1773

6279

2.27

202.83

2.0

1.9

0.23

g/l

0.63

1697

6013

Immunodeficiency with predominantly antibody defects

254

310

10.55

202.08

2.2

1.7

0.22

0.24

g/l

1.07

238

295

Hypertension, essential

2234

6111

2.12

201.84

1.9

1.7

0.25

0.23

g/l

26.33

2143

5846

Erysipelas

1576

5959

2.34

200.29

1.7

1.6

0.24

0.23

g/l

4.33

1495

5682

Cough

1302

4940

2.54

199.87

1.9

1.7

0.23

g/l

0.11

1246

4715

Codeine or tramadol medication

3286

9872

1.84

199.81

1.8

0.24

0.23

g/l

4.35

3121

9433

CR(E)ST syndrome

195

171

16.61

199.44

2.0

1.8

0.20

0.24

g/l

3.90

185

164

All-cause Heart Failure

1606

4862

2.37

198.34

1.8

1.5

0.24

g/l

0.42

1541

4616

Polyneuropathies and other disorders of the peripheral nervous system

809

2611

3.28

197.74

1.9

1.6

0.23

0.24

g/l

2.11

770

2481

Dental caries

903

2901

3.07

197.20

2.1

1.6

0.24

g/l

0.04

865

2755

Gout, FINNGEN

855

2829

3.13

195.98

1.5

0.26

0.24

g/l

11.01

819

2679

Pleural effusion

588

1557

4.02

195.51

2.0

1.5

0.24

g/l

0.17

563

1487

Polyarthrosis

700

1843

3.59

194.31

1.7

1.5

0.23

0.24

g/l

4.16

677

1753

Osteopathies and chondropathies

1803

7781

2.18

194.29

2.1

1.7

0.23

g/l

0.88

1728

7412

Other and unspecified polyneuropathies, also in other diseases

726

2232

3.45

192.55

1.9

1.6

0.23

0.24

g/l

1.64

692

2126

Lower back pain or/and sciatica

3181

11105

1.82

189.97

1.8

0.24

0.23

g/l

2.98

3028

10610

Caries of dentine

814

2597

3.17

188.06

2.1

1.6

0.24

g/l

0.12

779

2472

Seronegative rheumatoid arthritis

421

893

5.03

186.90

1.9

1.2

0.22

0.24

g/l

5.06

403

842

Acute upper respiratory infections

3029

10098

1.83

185.10

1.9

1.7

0.24

0.23

g/l

1.35

2891

9642

Parasetamol

1958

4641

2.18

184.93

1.9

1.7

0.24

0.23

g/l

3.71

1874

4425

Persons encountering health services for specific procedures and health care

3154

10477

1.81

184.81

1.8

0.24

0.23

g/l

2.74

3005

10015

Acute upper respiratory infections of multiple and unspecified sites

2351

8952

1.96

183.00

2.0

1.8

0.24

0.23

g/l

2.03

2241

8551

Other diseases of intestines

3078

9650

1.81

177.96

1.8

0.24

0.23

g/l

1.00

2947

9222

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

889

1416

3.22

177.66

1.9

1.6

0.23

g/l

0.85

842

1361

General examination and investigation of persons without complaint and reported diagnosis

1691

3953

2.27

177.55

1.9

1.6

0.23

0.24

g/l

4.57

1625

3800

Complications of surgical and medical care, not elsewhere classified

2910

10898

1.82

176.90

1.9

1.7

0.24

0.23

g/l

0.35

2769

10407

Hard cardiovascular diseases

2349

7234

1.96

175.32

1.8

1.7

0.24

0.23

g/l

3.71

2251

6891

Chronic nephritic syndrome

258

372

8.14

175.26

3.6

1.4

0.24

g/l

0.11

249

356

Biological medication for rheuma

763

2559

3.17

175.24

1.6

1.9

0.23

g/l

1.78

726

2445

Hypothyroidism (congenital or acquired)

753

1249

3.49

174.70

2.1

1.9

0.23

0.22

g/l

4.87

716

1197

Hypothyroidism and >3 levothyroxin purchases

742

1245

3.45

169.61

2.1

1.9

0.23

0.22

g/l

5.29

706

1193

Hypothyroidism, levothyroxine purchases

742

1245

3.45

169.61

2.1

1.9

0.23

0.22

g/l

5.29

706

1193

Codes for special purposes

1692

8204

2.11

168.68

1.9

1.8

0.24

0.23

g/l

2.36

1625

7823

Myalgia

852

3096

2.87

167.59

1.9

1.8

0.23

g/l

0.17

817

2943

Provisional assignment of new diseases of uncertain etiology

1687

8195

2.10

167.38

1.9

1.8

0.24

0.23

g/l

2.37

1621

7814

Obesity related asthma

1155

4883

2.46

166.07

1.6

1.8

0.26

0.23

g/l

17.30

1112

4635

IgA nephropathy (IgA glomerulonephritis)

210

259

10.20

165.09

1.6

1.5

0.27

0.24

g/l

4.14

197

248

Metabolic disorders

2686

8955

1.84

164.85

1.7

1.8

0.25

0.23

g/l

16.63

2550

8563

Other special examinations and investigations of persons without complaint or reported diagnosis

1687

3954

2.21

164.77

2.0

1.6

0.23

0.24

g/l

2.59

1603

3801

Cardiac arrhythmias

1789

5593

2.10

163.73

1.9

1.8

0.24

0.22

g/l

7.61

1707

5333

Other (seronegative) rheumatoid arthritis, wide

712

2384

3.16

163.69

2.0

1.7

0.22

0.24

g/l

6.26

677

2253

Covid-19 confirmed case

1192

5137

2.40

163.23

1.9

1.7

0.24

0.23

g/l

2.60

1140

4882

Disorders of eyelid, lacrimal system and orbit

2553

10420

1.83

162.52

2.1

1.7

0.23

0.24

g/l

3.49

2444

9937

Other abnormal immunological findings in serum

204

249

10.54

162.34

2.1

1.6

0.21

0.23

g/l

2.20

195

237

Pain (limb, back, neck, head abdominally)

1811

4347

2.13

161.74

1.8

1.7

0.23

g/l

0.01

1726

4160

Undetermined asthma, excluding more controls

457

1154

4.17

161.49

1.7

1.6

0.24

0.23

g/l

0.88

445

1095

Complications of medical and surgical care

2189

10600

1.90

161.16

1.9

1.7

0.24

0.23

g/l

1.56

2068

10133

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1271

3409

2.42

160.76

2.2

1.7

0.23

g/l

3.01

1219

3250

Intestinal infectious diseases

2745

11669

1.78

160.16

1.9

1.8

0.23

g/l

0.52

2601

11163

Persons encountering health services in other circumstances, wide

3155

9429

1.75

160.01

1.8

1.7

0.24

0.23

g/l

1.07

3032

8980

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3066

9427

1.76

159.42

1.9

1.7

0.24

0.23

g/l

1.09

2941

8978

Spondylopathies

2141

6605

1.96

159.05

1.6

1.7

0.24

g/l

0.67

2049

6299

Other dorsopathies, not elsewhere classified

2770

8071

1.81

159.02

1.8

0.23

g/l

0.09

2643

7716

Episodal and paroxysmal disorders

2998

8761

1.77

156.43

1.8

0.24

0.23

g/l

3.69

2868

8378

Diarrhoea and gastroenteritis of presumed infectious origin

2101

10093

1.90

155.02

1.9

1.8

0.24

0.23

g/l

1.00

1999

9649

Undetermined asthma

457

1192

4.03

154.41

1.7

1.6

0.24

0.23

g/l

0.97

445

1135

Pericarditis

209

273

8.72

153.74

3.2

1.4

0.23

0.24

g/l

0.48

198

260

Asthma/COPD (KELA code 203)

2704

10348

1.78

153.53

1.6

1.8

0.24

0.23

g/l

3.49

2584

9873

Atrial fibrillation and flutter

824

1864

2.94

153.45

1.8

1.6

0.24

0.23

g/l

3.37

789

1782

Certain infectious and parasitic diseases, including avohilmo

1832

4509

2.07

153.44

1.9

1.6

0.23

g/l

0.04

1745

4319

Allergic asthma (mode), excluding more controls

712

2391

3.01

153.16

1.6

1.8

0.24

0.23

g/l

2.17

671

2295

Symptoms and signs involving the nervous and musculoskeletal systems

1755

9003

2.00

153.04

1.9

1.7

0.23

g/l

1.12

1682

8585

Neurological diseases

2301

6167

1.91

153.01

1.8

0.23

g/l

0.86

2201

5903

Giant cell arteritis

227

331

7.80

151.64

1.7

1.2

0.26

0.24

g/l

0.90

214

311

Vocal cord dysfunction

396

803

4.52

151.29

1.8

1.2

0.23

0.24

g/l

0.62

369

766

Acute tubulo-interstitial nephritis

1727

7390

2.02

150.63

1.9

1.7

0.24

0.23

g/l

5.06

1644

7031

Isolated proteinuria

224

332

8.20

149.60

3.2

1.5

0.24

g/l

0.19

219

318

Nutritional anaemias

1474

6815

2.12

149.16

1.9

1.7

0.23

g/l

0.20

1410

6484

Haemorrhage from respiratory passages

949

3373

2.56

147.77

1.8

1.6

0.24

g/l

0.13

895

3209

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2634

11892

1.76

147.65

2.3

1.7

0.22

0.24

g/l

9.89

2514

11361

Other general symptoms and signs

273

485

6.14

147.30

1.7

0.23

0.22

g/l

0.68

260

463

Osteoporosis

846

2979

2.72

147.25

2.3

1.5

0.22

0.24

g/l

4.07

805

2806

Depression medications

782

1304

3.10

146.56

1.9

0.24

0.22

g/l

8.09

751

1251

Allergic asthma (mode)

712

2452

2.93

146.36

1.6

1.8

0.24

0.23

g/l

2.15

671

2356

STROKE

1492

4795

2.15

146.12

1.9

1.7

0.24

0.23

g/l

1.96

1424

4568

Diseases of salivary glands

1104

4843

2.37

146.07

2.3

1.8

0.22

0.23

g/l

4.71

1059

4615

Iron deficiency anaemia

1301

5969

2.20

145.72

1.9

1.7

0.23

g/l

0.03

1249

5680

Transplanted organ and tissue status

428

1124

4.12

145.07

1.9

1.6

0.25

0.24

g/l

3.27

406

1069

Hypertensive heart and/or renal disease

697

1711

3.08

145.03

1.6

1.5

0.25

0.23

g/l

7.73

668

1632

Nerve, nerve root and plexus disorders

2952

10511

1.72

144.94

1.7

1.8

0.24

0.23

g/l

0.86

2814

10028

Other disorders of fluid, electrolyte and acid-base balance

932

3555

2.55

144.93

1.7

1.6

0.23

g/l

0.79

881

3385

Acute sinusitis

1616

7432

2.03

144.19

1.9

1.8

0.23

g/l

0.78

1542

7098

Other and unspecified iron deficiency

1085

4735

2.37

144.13

1.9

1.7

0.23

g/l

0.08

1040

4496

Infections of the skin and subcutaneous tissue

1772

9184

1.95

142.34

2.1

1.7

0.24

0.23

g/l

2.65

1698

8793

Diseases of the respiratory system

1608

3880

2.12

141.99

1.9

1.7

0.23

g/l

0.37

1526

3716

Gout, idiopatic and unspecified

737

2715

2.83

141.17

1.5

0.26

0.24

g/l

12.00

708

2585

Rheumatism, unspecified

509

1525

3.54

140.88

2.0

1.7

0.24

0.23

g/l

0.85

490

1440

Idiopathic pulmonary fibrosis

305

640

5.16

137.97

1.8

1.4

0.22

0.24

g/l

1.88

295

608

Sciatica+with lumbago

1502

6649

2.05

137.80

1.7

1.8

0.24

g/l

0.91

1426

6350

Other acute lower respiratory infections

1575

7662

2.01

137.72

1.9

1.7

0.24

0.23

g/l

1.02

1504

7308

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2823

10807

1.70

137.01

1.9

1.7

0.23

g/l

0.01

2703

10329

Complications of procedures, not elsewhere classified

2298

10571

1.79

136.95

1.9

1.7

0.24

0.23

g/l

0.21

2185

10094

Disturbances of skin sensation

966

4120

2.44

136.55

1.9

0.23

0.24

g/l

0.78

920

3947

Other headache syndromes

1298

6208

2.14

136.41

1.9

1.8

0.23

g/l

0.63

1244

5927

Diabetic nephropathy, excluding more controls

563

1452

3.36

135.42

1.6

1.7

0.27

0.25

g/l

5.04

540

1399

Chronic sinusitis

1301

6260

2.14

135.41

1.8

0.24

0.23

g/l

0.38

1243

5988

Intestinal infectious diseases, including avohilmo, including avohilmo

3134

10658

1.66

135.24

1.9

1.7

0.23

g/l

0.10

2986

10189

Bacterial pneumoniae

1124

4444

2.28

135.07

2.0

1.6

0.24

0.23

g/l

0.78

1055

4223

Other diseases of blood and blood-forming organs, wide

761

2928

2.72

134.48

2.3

1.7

0.22

0.24

g/l

4.13

717

2794

Abnormal findings on examination of urine, without diagnosis

258

484

6.06

134.38

3.0

1.5

0.24

g/l

0.28

251

463

Gastro-oesophageal reflux disease

1917

8846

1.87

133.00

1.8

1.7

0.23

0.24

g/l

2.70

1822

8459

Asthma and allergy

449

1262

3.67

132.99

1.7

1.8

0.24

0.22

g/l

3.58

425

1216

Non-allergic asthma (mode), excluding more controls

527

1653

3.27

131.60

1.8

1.6

0.23

g/l

0.14

507

1568

Chronic rhinitis, nasopharyngitis and pharyngitis

1042

4682

2.30

129.81

1.9

1.8

0.24

0.23

g/l

0.99

988

4482

Migraine with aura

887

3725

2.47

129.52

2.0

0.22

0.23

g/l

1.89

848

3573

Ischemic heart diseases

2171

7249

1.82

129.36

1.8

1.7

0.24

g/l

3.43

2075

6913

Kidney transplant status

278

575

5.42

129.33

2.1

1.5

0.26

0.23

g/l

3.44

264

546

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

248

463

5.99

129.27

2.0

1.7

0.22

0.23

g/l

0.96

237

438

Non-ischemic cardiomyopathy

854

2733

2.56

128.91

1.8

1.5

0.24

0.23

g/l

0.47

819

2586

Defects in the complement system

118

21.42

128.90

2.5

1.5

0.19

0.23

g/l

3.49

100

Gout, unspecified

614

2158

2.97

128.71

1.5

0.27

0.23

g/l

12.90

589

2057

Temporal arteritis

193

282

7.77

128.70

1.8

1.2

0.25

0.24

g/l

0.48

181

263

Idiopathic urticaria

189

275

8.40

128.57

1.7

1.6

0.23

g/l

0.58

181

260

Bacterial pneumonia, not elsewhere classified

1056

4154

2.29

128.55

2.0

1.6

0.24

0.23

g/l

0.83

991

3952

Anxiety disorders

2565

10467

1.71

128.16

1.9

1.8

0.23

g/l

0.60

2442

10010

Dorsopathies

2707

8118

1.72

128.14

1.8

0.23

g/l

0.15

2586

7762

Pulmonary heart disease, diseases of pulmonary circulation

925

3975

2.41

127.90

1.9

1.6

0.25

0.23

g/l

4.02

877

3766

Hypothyroidism, drug reimbursement

442

830

3.87

127.81

2.0

1.8

0.23

0.22

g/l

1.28

421

796

Other disorders of skin and subcutaneous tissue, not elsewhere classified

511

1628

3.31

127.81

2.1

1.6

0.23

0.24

g/l

0.43

483

1548

Spondylosis

1458

5744

2.03

127.49

1.6

1.7

0.24

g/l

0.02

1392

5471

Diseases of the eye and adnexa

2145

5952

1.84

127.37

2.0

1.7

0.23

g/l

0.31

2056

5698

Neurotic, stress-related and somatoform disorders

2545

10429

1.71

127.25

1.9

1.8

0.23

g/l

0.61

2423

9972

Anxiety disorders, excluding more controls

2331

8632

1.76

126.09

1.9

1.8

0.23

g/l

0.04

2214

8259

Heart failure and coronary heart disease

1073

3347

2.31

126.03

1.7

1.5

0.24

0.23

g/l

1.41

1029

3169

Tumor necrosis factor alpha inhibitors

635

2316

2.90

125.13

1.6

1.9

0.23

g/l

1.39

601

2208

Asthma and allergy, excluding more controls

449

1318

3.52

124.51

1.7

1.8

0.24

0.23

g/l

3.10

425

1264

Gastrointestinal diseases

1568

3943

2.03

124.43

2.0

1.8

0.23

g/l

0.54

1489

3790

Atrial fibrillation and flutter with reimbursement

632

1347

3.05

124.41

1.7

1.6

0.24

0.23

g/l

2.49

608

1282

Percutaneous Coronary Intervention

2039

6917

1.83

124.34

1.7

0.24

g/l

2.65

1951

6602

Non-allergic asthma (mode)

528

1716

3.16

124.20

1.8

1.6

0.23

g/l

0.21

508

1632

Noninfective enteritis and colitis

1389

7067

2.02

123.86

1.7

1.8

0.23

g/l

0.04

1323

6760

Viral infections characterized by skin and mucous membrane lesions

1278

6322

2.08

123.71

2.4

1.7

0.23

g/l

1.87

1219

6038

Chronic ulcer of skin, not elsewhere classified

283

613

5.00

123.30

2.0

1.4

0.24

g/l

0.33

267

585

Other and unspecified coagulation defects

286

632

5.07

123.04

3.8

1.9

0.21

0.23

g/l

2.07

276

600

Symptoms and signs concerning food and fluid intake

363

950

4.02

122.07

2.0

1.6

0.23

g/l

0.48

348

897

Gout, strict definition

550

1878

3.07

121.63

1.5

0.27

0.24

g/l

11.15

524

1789

Exposure to unspecified factor

2814

11813

1.65

121.54

1.8

0.24

0.23

g/l

4.70

2683

11287

Coronary revascularization (ANGIO or CABG)

2030

6923

1.82

121.14

1.7

0.24

g/l

2.50

1942

6606

Syncope and collapse

1067

4082

2.23

121.13

1.8

1.6

0.23

g/l

0.00

1023

3889

Bacterial pneumonia (organism specified)

1212

5350

2.10

119.76

2.0

1.6

0.24

0.23

g/l

0.84

1138

5088

Venous thromboembolism

1446

7256

1.97

119.60

1.9

1.6

0.24

g/l

3.38

1376

6899

Osteoporosis with pathological fracture (FG)

241

466

5.52

119.28

2.3

1.2

0.23

0.24

g/l

1.49

228

436

Oxycodone

1027

4011

2.25

118.54

1.7

1.6

0.24

0.23

g/l

3.26

974

3815

Psoriatic and enteropathic arthropathies

361

965

3.93

118.09

1.6

1.2

0.24

g/l

0.45

348

917

Diabetic nephropathy

566

1976

3.00

118.07

1.6

1.5

0.27

0.25

g/l

4.83

543

1899

Secondary right heart disease

216

386

6.27

118.07

1.8

1.5

0.24

0.23

g/l

0.14

208

369

Non-rheumatic valve diseases

1170

3965

2.16

117.79

1.9

1.6

0.23

0.24

g/l

3.74

1113

3763

Valvular heart disease excluding rheumatic fever

1177

4004

2.15

117.58

1.9

1.6

0.23

0.24

g/l

3.38

1119

3801

Other intervertebral disc disorders

2139

7323

1.77

117.56

1.6

1.8

0.23

0.24

g/l

0.12

2023

6988

Implicit fungal Sepsis, including avohilmo

310

752

4.46

117.21

1.8

1.6

0.24

0.23

g/l

0.82

288

717

Other symptoms and signs involving the nervous and musculoskeletal systems

1255

6307

2.05

116.57

1.9

1.7

0.23

g/l

1.33

1207

6015

Heart failure and bmi 25plus

902

2560

2.42

116.35

1.7

1.5

0.25

g/l

0.22

863

2431

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

390

1118

3.75

116.31

1.6

1.8

0.25

0.23

g/l

2.20

367

1066

Other/unspecified dorsalgia

1070

5002

2.17

116.26

1.8

0.24

0.23

g/l

0.62

1019

4773

Acute bronchitis

1181

5689

2.09

116.19

1.9

1.7

0.24

0.23

g/l

1.70

1127

5424

Allergic purpura

198

336

6.83

115.11

1.7

1.6

0.24

g/l

0.15

186

324

Preparatory care for dialysis

232

457

5.73

114.40

1.9

1.5

0.26

0.24

g/l

3.47

224

436

Major coronary heart disease event

2126

7361

1.76

113.97

1.7

0.24

g/l

2.92

2035

7020

All influenza

760

3151

2.49

113.85

1.9

1.6

0.23

g/l

0.15

722

3001

Other and unspecified immunodeficiencies with predominantly antibody defects

135

156

11.78

113.20

1.9

1.7

0.23

g/l

0.11

123

151

Gonarthrosis [arthrosis of knee](FG)

1494

4442

1.97

112.94

1.6

1.2

0.24

0.25

g/l

1.09

1432

4220

Emergency coronary revascularization (for ACS)

2139

7516

1.75

112.61

1.7

0.24

g/l

2.05

2048

7163

Genitourinary diseases

1353

3347

2.06

112.34

1.8

1.5

0.24

0.23

g/l

2.68

1311

3182

Arthrosis

1625

4739

1.91

111.53

1.7

1.6

0.24

g/l

0.48

1560

4518

Other pleural conditions

346

939

3.90

111.16

2.0

1.5

0.24

g/l

0.35

334

891

Disorders of conjunctiva

2368

11170

1.67

110.86

2.0

1.8

0.23

g/l

0.57

2269

10669

Diseases of liver

1013

4798

2.18

110.69

1.8

1.7

0.23

0.24

g/l

2.40

957

4584

Other pulmonary heart/vessel disease

222

431

5.71

110.67

1.8

1.5

0.24

0.23

g/l

0.34

214

414

Other coagulation defects

339

919

4.00

110.13

3.5

1.8

0.21

0.23

g/l

2.55

328

871

Spondylopathies (FG)

405

1223

3.46

110.01

1.7

1.2

0.24

g/l

0.62

387

1159

Abnormalities of heart beat

973

4392

2.20

109.88

2.1

1.7

0.23

g/l

0.15

930

4187

Bleeding

2128

8813

1.72

109.59

1.8

1.7

0.24

0.23

g/l

0.97

2013

8428

Atopic dermatitis

1668

7374

1.84

109.32

1.9

1.8

0.23

g/l

1.36

1596

7066

Visual disturbances and blindness

1490

8106

1.88

108.48

1.9

1.7

0.23

g/l

0.37

1426

7726

Symptoms and signs involving the digestive system and abdomen

2503

7604

1.67

108.37

1.8

1.7

0.24

0.23

g/l

0.47

2376

7287

Seropositive rheumatoid arthritis, strict definition

528

1886

2.95

108.21

1.6

1.7

0.21

0.24

g/l

6.67

506

1787

Symptoms and signs involving cognition, perception, emotional state and behaviour

2607

10866

1.63

107.60

1.8

0.23

g/l

0.03

2457

10408

Migraine without aura

719

3005

2.49

106.41

1.9

2.0

0.23

g/l

0.06

689

2887

Other arthrosis

1217

4061

2.05

106.27

1.7

1.6

0.24

g/l

0.32

1169

3867

Abdominal and pelvic pain

2486

7604

1.67

105.74

1.8

1.7

0.24

0.23

g/l

0.42

2360

7287

Endocrine, nutritional and metabolic diseases

2043

5961

1.76

105.46

1.9

0.24

0.22

g/l

20.80

1955

5695

Explicit bacterial Sepsis

356

1021

3.67

105.16

2.4

1.6

0.24

g/l

0.47

336

978

Explicit bacterial Sepsis, including avohilmo

364

1061

3.61

104.88

2.3

1.6

0.24

0.23

g/l

0.56

344

1012

Visual disturbances

1403

7582

1.90

104.87

1.9

1.7

0.23

g/l

0.31

1344

7225

Conjunctivitis

2171

10590

1.68

104.36

2.0

1.8

0.23

g/l

0.44

2083

10109

Other and unspecified drugs and medicaments

361

1058

3.67

104.22

1.6

1.8

0.25

0.23

g/l

1.76

338

1010

Coxarthrosis [arthrosis of hip](FG)

1074

3543

2.12

104.10

1.7

1.2

0.24

0.25

g/l

2.41

1028

3366

Other functional intestinal disorders

1260

5950

1.97

103.94

1.8

1.7

0.23

g/l

0.13

1199

5672

Other disorders of urethra and urinary system

1930

7839

1.74

103.71

1.8

1.7

0.24

0.23

g/l

1.14

1826

7485

Irritable bowel syndrome

870

3985

2.26

103.62

1.8

0.23

g/l

0.67

835

3794

Depression

2593

10904

1.62

103.52

1.8

0.24

0.23

g/l

0.68

2474

10432

Thrombocytopenia, unspecified

298

770

4.18

103.44

2.7

1.6

0.20

0.24

g/l

8.25

273

739

Hypertensive Renal Disease

164

253

7.09

103.16

1.4

0.26

0.23

g/l

4.68

156

239

Other noninfective gastroenteritis and colitis

774

3386

2.37

102.91

1.8

0.23

g/l

0.22

742

3228

Mood disorders, excluding more controls

2472

8986

1.64

102.88

1.8

1.7

0.24

0.23

g/l

0.71

2350

8598

Care involving use of rehabilitation procedures

1724

8904

1.77

102.80

1.9

1.7

0.23

g/l

0.09

1624

8495

Budesonide

414

1323

3.26

102.50

1.7

1.4

0.22

0.24

g/l

2.65

390

1265

Diseases of the digestive system

1219

6283

1.97

102.50

1.8

1.7

0.23

g/l

2.49

1154

5990

Shoulder lesions

1854

6375

1.77

102.33

1.7

0.24

g/l

0.26

1774

6070

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2643

10560

1.61

101.99

1.8

0.24

0.23

g/l

2.64

2522

10087

Other arrhythmias

1667

7028

1.80

101.91

1.8

1.7

0.23

0.24

g/l

0.45

1595

6707

Dysphagia

714

3028

2.43

101.85

1.8

1.6

0.23

g/l

0.42

683

2890

Dermatographic urticaria

312

845

4.00

101.60

1.7

2.0

0.23

g/l

0.08

293

802

Giant cell arteritis with polymyalgia rheumatica

193

360

6.05

101.09

1.8

1.5

0.25

0.23

g/l

1.45

181

340

Persons encountering health services for examination and investigation

1483

3954

1.91

99.79

1.9

1.6

0.23

0.24

g/l

1.23

1404

3801

Mood [affective] disorders

2720

11158

1.58

99.65

1.8

0.24

0.23

g/l

0.86

2588

10674

DVT of lower extremities and pulmonary embolism

1089

5476

2.03

99.49

1.9

1.6

0.25

0.23

g/l

4.16

1030

5201

Mood disorders

2722

11166

1.58

98.95

1.8

0.24

0.23

g/l

0.89

2590

10681

Nausea and vomiting

782

3397

2.31

98.86

1.8

1.7

0.24

0.23

g/l

1.40

738

3253

Symptoms and signs involving the urinary system

1965

8858

1.70

98.29

1.8

1.7

0.24

0.23

g/l

0.43

1863

8470

Vasomotor and allergic rhinitis

1118

5591

2.00

98.11

1.7

1.9

0.23

g/l

0.26

1060

5365

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1628

9206

1.77

97.16

1.9

1.7

0.24

0.23

g/l

0.48

1543

8790

Other diseases of upper respiratory tract

2751

9162

1.59

97.13

1.7

1.8

0.23

g/l

0.38

2607

8763

Migraine with aura and triptan purchases

612

2489

2.57

96.70

1.9

2.1

0.22

0.23

g/l

0.67

588

2382

Other nutritional deficiencies

1910

10500

1.69

96.37

1.7

1.9

0.26

0.23

g/l

36.82

1831

10033

Mycoses

846

3963

2.21

95.37

2.0

1.8

0.23

g/l

0.21

815

3780

Disorders of skin appendages

1455

8166

1.81

94.27

2.1

1.8

0.23

g/l

0.26

1373

7824

Peripheral artery disease

999

3876

2.08

94.21

1.5

0.24

g/l

1.34

958

3666

Sleep apnoea

2458

9816

1.60

94.21

1.7

0.25

0.23

g/l

23.80

2349

9360

Candidiasis, including avohilmo

952

4702

2.09

93.30

2.0

1.8

0.23

g/l

0.40

909

4488

Other reaction to severe stress, and adjustment disorders

1112

5786

1.97

93.27

2.2

1.9

0.23

g/l

0.63

1064

5548

Pulmonary embolism

795

3666

2.23

92.94

1.9

1.6

0.25

0.23

g/l

4.61

752

3478

Disorders of the thyroid gland

2455

10137

1.59

92.61

1.9

1.8

0.23

g/l

0.49

2336

9686

Liquid cancers

818

3609

2.21

92.13

1.7

1.6

0.23

0.24

g/l

0.42

762

3430

Disorders resulting from impaired renal tubular function

192

388

5.56

91.99

2.0

1.6

0.27

0.24

g/l

3.84

182

372

Disorders of sclera, cornea, iris and ciliary body

1515

8714

1.78

91.87

2.0

1.7

0.23

g/l

0.02

1441

8324

Other diseases of urinary system

2530

9071

1.59

91.31

1.9

1.7

0.23

g/l

0.05

2404

8685

Pulmonary heart disease

795

3695

2.22

91.13

1.9

1.6

0.25

0.23

g/l

4.56

752

3503

Zoster [herpes zoster], including avohilmo

1381

7470

1.82

90.92

2.3

1.6

0.22

0.24

g/l

8.67

1321

7114

Other CVD (FINNGEN)

308

640

3.82

90.33

1.7

1.6

0.24

0.23

g/l

2.88

290

606

Persons encountering health services in other circumstances

1136

5948

1.93

90.31

2.0

1.8

0.23

g/l

0.46

1104

5667

5-aminosalicylic acid

537

2110

2.62

90.20

1.6

1.4

0.23

0.24

g/l

2.19

506

2024

Adalimumab

398

1355

3.12

89.45

1.5

1.9

0.23

g/l

0.90

377

1289

Streptococcal septicaemia, including avohilmo

298

847

3.71

89.42

2.2

1.5

0.25

0.23

g/l

1.98

278

810

Streptococcal septicaemia

292

820

3.76

89.23

2.2

1.5

0.25

0.23

g/l

1.77

272

784

Atherosclerosis, excluding cerebral and coronary sclerosis

926

3550

2.10

88.78

1.5

0.24

g/l

0.67

884

3358

Disorders of lipoprotein metabolism and other lipidaemias

1988

7372

1.66

88.13

1.6

1.7

0.25

0.23

g/l

22.20

1890

7037

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2449

9951

1.58

88.10

1.9

1.7

0.23

0.24

g/l

0.86

2338

9493

Hypothyroidism, other/unspecified

2304

9636

1.60

87.49

1.8

0.23

g/l

0.81

2179

9208

Polyarthritis, unspecified

162

292

6.09

87.37

2.1

1.7

0.23

0.24

g/l

0.53

156

283

All anxiety disorders

1754

8162

1.70

87.36

1.8

0.23

g/l

0.30

1676

7806

Anxiety (asthma-related co-morbidities)

1711

7744

1.71

87.20

1.8

1.9

0.23

g/l

0.01

1637

7410

Other bacterial intestinal infections

543

2188

2.58

87.03

1.9

1.7

0.23

g/l

0.18

505

2086

Acquired haemolytic anaemia

151

259

6.75

86.94

3.8

1.4

0.19

0.24

g/l

6.69

136

249

Hypothyreosis and Thyroxine purchase for inclusion criteria

2398

10110

1.58

86.50

1.9

1.8

0.23

g/l

1.02

2268

9664

Hypermobility syndrome

237

592

4.34

86.43

1.9

1.3

0.22

0.24

g/l

1.77

225

556

Early onset COPD, excluding more controls

450

1651

2.80

86.34

1.7

1.4

0.24

g/l

0.32

428

1571

Spondyloarthritis

494

1907

2.68

86.27

1.7

1.3

0.24

g/l

0.49

472

1812

Lumbar disc prolapse

1609

6987

1.73

86.18

1.6

1.8

0.23

0.24

g/l

0.27

1526

6671

Continuous positive airway pressure

473

1458

2.79

85.96

1.7

1.6

0.25

0.23

g/l

4.12

440

1393

Other/unspecified rheumatoid arthritis

401

1398

3.02

85.95

2.0

1.6

0.21

0.24

g/l

9.80

377

1332

Rosacea

468

1774

2.78

85.73

2.4

1.9

0.22

0.23

g/l

0.99

447

1688

Other disorders of kidney and ureter

425

1535

2.91

85.32

1.8

1.6

0.26

0.24

g/l

3.91

406

1465

Sleep apnoea, including avohilmo

2553

10081

1.55

84.98

1.7

1.8

0.25

0.23

g/l

26.09

2439

9608

Cerebrovascular diseases

1765

7363

1.69

84.93

1.8

1.6

0.24

g/l

2.81

1687

7010

Paroxysmal tachycardia

560

1884

2.54

84.74

1.8

1.7

0.24

0.22

g/l

4.10

531

1791

Dizziness and giddiness

1957

9454

1.64

84.74

1.7

0.24

0.23

g/l

0.36

1853

9049

Hypertensive Heart Disease

536

1598

2.61

84.32

1.7

1.5

0.25

0.23

g/l

5.02

510

1526

COPD (mode)

618

2031

2.42

84.27

1.5

1.4

0.24

g/l

0.70

591

1922

L04AC Interleukin inhibitors

288

840

3.70

84.02

1.8

1.7

0.23

0.24

g/l

0.51

278

798

Other and unspecified rosacea

358

1191

3.20

83.90

2.4

1.9

0.22

0.23

g/l

1.59

339

1133

Fungal Sepsis

187

398

5.13

83.68

1.8

1.6

0.24

0.23

g/l

0.57

174

381

Somatoform disorder

544

2242

2.53

83.41

1.9

1.8

0.23

g/l

1.04

507

2137

Follow-up examination after treatment for conditions other than malignant neoplasms

1024

3486

1.99

83.15

1.9

1.6

0.23

0.24

g/l

0.51

969

3350

Sleep disorders (combined)

2774

9614

1.53

83.09

1.7

1.8

0.24

0.23

g/l

6.83

2648

9166

Disorders of other endocrine glands

1226

6719

1.84

82.96

2.1

1.8

0.24

0.23

g/l

1.45

1161

6411

Atopic dermatitis, strict definition with reimbursement

877

4203

2.06

82.69

1.8

1.9

0.23

g/l

0.32

840

4034

Other bacterial intestinal infections, including avohilmo

674

3056

2.28

82.40

1.9

1.7

0.23

g/l

0.08

625

2912

Haemolytic anaemias

177

367

5.38

82.20

3.5

1.5

0.20

0.24

g/l

6.66

162

351

Other anxiety disorders

1350

6561

1.79

81.70

1.9

0.23

g/l

0.29

1294

6287

Other antidepressants

2540

8464

1.55

81.56

1.8

0.24

0.23

g/l

3.82

2438

8082

Diverticular disease of intestine

1693

6323

1.69

80.48

1.7

1.6

0.24

g/l

0.35

1614

6023

Sequelae of external causes of morbidity and mortality

733

3481

2.17

79.84

1.6

1.7

0.24

0.23

g/l

1.93

698

3309

Disorders of synovium and tendon

1337

6495

1.78

79.81

1.7

0.23

g/l

0.10

1285

6185

Primary_lymphoid and hematopoietic malignant neoplasms

637

2868

2.29

79.28

1.7

1.6

0.23

0.24

g/l

0.15

591

2728

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1330

7395

1.77

79.27

1.8

0.24

g/l

0.59

1246

7077

Conjunctivitis (acute, non atopic), including avohilmo

2539

10174

1.53

78.39

2.0

1.7

0.23

0.24

g/l

2.50

2421

9717

Viral pneumonia

394

1427

2.88

78.35

2.2

1.5

0.24

g/l

0.66

379

1363

Implicit fungal Sepsis

174

369

5.16

78.27

1.9

1.6

0.24

0.23

g/l

0.58

161

354

Allergic rhinitis

920

4709

1.98

78.23

1.7

1.9

0.23

g/l

0.09

875

4550

Zoster [herpes zoster]

541

2293

2.45

77.74

2.7

1.6

0.22

0.24

g/l

2.35

515

2161

Rotator cuff syndrome

1446

5816

1.74

77.43

1.7

1.6

0.24

g/l

0.09

1381

5535

Diseases of the myoneural junction and muscle

386

1396

2.90

77.24

2.7

1.5

0.22

0.24

g/l

2.69

374

1329

Type 2 diabetes, wide definition

1892

7452

1.62

77.01

1.5

1.8

0.26

0.23

g/l

37.02

1818

7075

Other viral diseases, including avohilmo

1113

6110

1.85

76.67

2.1

1.9

0.23

g/l

0.19

1063

5868

Cystitis

2143

8207

1.58

75.78

2.0

1.7

0.23

g/l

0.76

2044

7843

Other diseases of lip and oral mucosa

1158

6530

1.82

75.54

2.0

1.8

0.22

0.24

g/l

3.98

1103

6234

Bacterial intestinal infections, IBD co-morbidities

537

2299

2.42

75.42

1.9

1.7

0.23

g/l

0.21

500

2184

Hernia of abdominal wall, postoperative

434

1667

2.66

75.12

1.5

1.6

0.25

0.24

g/l

1.62

404

1607

Biological medicines for asthma

144

274

6.07

74.44

1.7

1.6

0.24

g/l

0.10

139

263

Cutaneous abscess, furuncle and carbuncle

751

3695

2.09

74.38

2.0

1.7

0.24

0.23

g/l

2.41

719

3524

Recurrent or chronic depression

1076

4047

1.88

74.36

1.9

1.8

0.23

g/l

0.19

1036

3877

Convulsions, not elsewhere classified

546

2328

2.37

74.35

2.0

1.6

0.22

0.23

g/l

1.03

508

2227

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1478

8931

1.68

73.92

1.9

1.7

0.24

0.23

g/l

0.32

1398

8517

Primary biliary cholangitis (PBC)

102

136

8.37

73.58

2.0

1.2

0.21

0.25

g/l

4.37

128

Ischaemic heart disease, wide definition

1771

6769

1.64

73.57

1.8

1.6

0.24

g/l

3.59

1698

6450

Symptoms and signs involving speech and voice

911

4817

1.94

73.24

1.9

1.7

0.23

g/l

0.55

864

4573

Intracranial trauma

1349

5296

1.75

73.12

1.8

0.24

0.23

g/l

1.76

1286

5067

Depression or dysthymia

1625

5369

1.68

72.77

1.8

1.7

0.24

g/l

0.36

1554

5130

Hyperlipidaemia, other/unspecified

900

4240

1.95

72.48

1.6

0.25

0.23

g/l

11.21

853

4041

Subjective visual disturbances

742

3674

2.08

72.36

2.1

1.8

0.23

g/l

0.13

710

3493

Chronic gastritis

666

3170

2.16

71.87

1.8

1.6

0.23

0.24

g/l

0.98

635

3007

Obesity and other hyperalimentation

1730

10289

1.61

71.83

1.6

1.9

0.26

0.23

g/l

47.55

1658

9828

Concussion

1184

5209

1.79

71.69

1.8

0.23

g/l

0.96

1127

4985

Obesity

1722

10254

1.61

71.59

1.6

1.9

0.26

0.23

g/l

47.87

1650

9795

Diagnoses used for exclusion with ILD

658

3128

2.16

71.36

1.7

1.6

0.24

g/l

0.04

634

2971

Liquid cancers, including Hilmo

922

4317

1.93

71.34

1.7

1.6

0.23

0.24

g/l

0.73

865

4108

Hyperkalaemia

196

488

4.26

71.28

1.5

0.25

0.23

g/l

1.98

183

470

Dermatitis due to substances taken internally

203

522

4.16

70.87

2.8

1.8

0.22

0.23

g/l

0.68

193

497

Triptan medication for migraine, min. 3 purchases

1625

7531

1.64

70.87

1.9

0.23

g/l

2.63

1564

7212

Enterocolitis due to Clostridium difficile

326

1127

3.02

70.82

1.8

1.6

0.24

g/l

0.42

302

1070

Mycoses, including avohilmo

2362

12115

1.50

70.81

1.9

1.8

0.23

g/l

1.01

2264

11562

Urinary track infection

1666

5111

1.66

70.16

2.0

1.9

0.23

g/l

0.06

1597

4875

Allergic urticaria

303

1018

3.15

69.71

2.1

1.9

0.24

0.23

g/l

1.72

293

967

Migraine without aura and triptan purchases

570

2593

2.28

69.65

1.9

2.1

0.23

g/l

0.31

548

2488

Cardiomyopathy

409

1603

2.63

69.16

1.6

1.5

0.24

g/l

0.08

384

1515

Bronchiectasis

254

771

3.48

69.13

1.8

1.5

0.23

g/l

0.19

243

730

Other disorders of white blood cells

217

598

3.91

68.98

2.0

1.7

0.22

0.24

g/l

1.01

204

569

Pain in thoracic spine

452

1867

2.51

68.78

1.9

1.8

0.23

g/l

1.03

432

1774

Disorders of lens

1564

5947

1.66

68.54

2.0

1.6

0.24

g/l

0.08

1493

5682

Papulosquamous disorders

1029

5786

1.82

67.81

1.7

1.8

0.24

0.23

g/l

3.09

986

5515

Reactive arthropathies, FINNGEN

211

573

3.87

67.80

2.8

1.2

0.23

0.24

g/l

0.97

205

544

Other viral diseases

836

4403

1.94

67.29

2.1

1.8

0.23

g/l

0.36

797

4220

Rash and other nonspecific skin eruption

330

1187

2.93

67.01

2.4

1.8

0.23

g/l

0.65

318

1130

Unspecified haematuria

988

4433

1.85

66.93

1.7

1.6

0.25

0.24

g/l

2.84

946

4224

Spinal stenosis

1116

4672

1.79

66.90

1.5

1.6

0.24

g/l

0.20

1068

4438

Hypo-osmolality and hyponatraemia

457

1903

2.46

66.86

1.9

1.6

0.22

0.23

g/l

1.19

432

1809

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1502

8960

1.63

66.85

2.0

1.8

0.23

g/l

0.51

1433

8548

Other diseases of the respiratory system

516

2289

2.32

66.56

1.6

0.25

0.24

g/l

1.60

487

2177

Other respiratory disorders and diseases

516

2289

2.32

66.56

1.6

0.25

0.24

g/l

1.60

487

2177

Insulin, combination of fast acting with intermediate-acting or long-acting

1449

8101

1.65

66.49

1.5

1.7

0.26

0.23

g/l

20.61

1382

7728

Peripheral artery operations in Hilmo

320

1131

2.93

66.39

1.6

1.5

0.25

0.24

g/l

0.98

306

1073

Pure hypercholesterolaemia

1708

6856

1.60

66.25

1.6

1.7

0.25

0.23

g/l

16.43

1625

6550

Idiopathic thrombocytopenic purpura

153

337

5.06

66.23

4.1

1.5

0.20

0.24

g/l

5.15

143

321

Other neurological diseases

1711

8489

1.59

65.52

1.7

0.23

0.24

g/l

0.28

1620

8098

Fibrosis and cirrhosis of liver

262

843

3.29

64.96

1.5

1.6

0.21

0.24

g/l

6.88

247

806

Thyroiditis, ILD-related definition

348

1305

2.78

64.94

2.2

1.3

0.22

0.24

g/l

2.61

338

1235

Insulin medication

1449

7432

1.64

64.86

1.5

1.8

0.26

0.23

g/l

27.42

1382

7085

Nonhereditary hypogammaglobulinemia

139

8.58

64.82

3.1

1.5

0.24

0.23

g/l

0.21

132

Anaemia in chronic diseases classified elsewhere

122

225

6.07

64.70

2.1

1.4

0.25

0.23

g/l

1.68

112

215

Amputation

278

924

3.14

64.65

1.6

1.5

0.25

0.24

g/l

1.60

264

873

Other diseases of arteries and capillaries

279

938

3.12

63.87

1.8

1.7

0.24

g/l

0.32

259

890

Insulin, fast-acting

908

5004

1.85

63.80

1.5

1.7

0.25

0.23

g/l

11.64

867

4781

Hypothyroidism, strict autoimmune, 3 medication purchases required

2109

9496

1.51

63.69

1.8

0.23

g/l

0.61

1998

9073

Gonarthrosis

1271

4224

1.72

63.53

1.6

0.24

g/l

0.56

1216

4024

Myocarditis

152

340

4.72

63.40

2.1

1.6

0.23

g/l

0.39

146

327

Allergic conjunctivitis

1567

9610

1.60

63.33

2.0

1.8

0.23

g/l

0.36

1494

9171

Drug-induced osteoporosis with pathological fracture

108

183

6.95

63.30

2.6

1.7

0.23

g/l

0.14

102

174

Soft tissue disorders related to use, overuse and pressure

680

3424

2.03

63.00

1.9

1.6

0.24

g/l

0.04

643

3246

Temporomandibular joint disorders, including avohilmo

1289

7609

1.67

62.99

2.0

1.9

0.23

g/l

2.05

1231

7272

Reactive arthropathies

252

805

3.27

62.83

2.7

1.5

0.23

0.24

g/l

0.96

242

765

Other gastritis (incl. Duodenitis)

563

2650

2.18

62.73

1.7

1.6

0.24

g/l

0.13

535

2519

Inflammatory bowel disease

851

4630

1.88

62.62

1.6

1.9

0.23

g/l

0.13

806

4429

Voice disturbances

740

3854

1.97

62.51

1.9

1.8

0.23

g/l

0.86

705

3660

Functional dyspepsia

716

3687

1.99

62.34

1.8

1.7

0.24

g/l

0.06

680

3507

Constipation

2197

10112

1.49

62.06

1.8

1.7

0.23

g/l

0.74

2084

9665

Other skin changes

541

2522

2.21

61.97

1.9

1.7

0.23

g/l

0.54

519

2394

Any mental disorder

2618

9113

1.45

61.81

1.9

1.7

0.24

0.23

g/l

0.85

2497

8716

Other complications of surgical and medical care, not elsewhere classified

329

1233

2.80

61.73

1.8

0.23

g/l

0.05

318

1173

Noninfectious colitis NAS

416

1743

2.48

61.60

2.0

1.8

0.24

0.23

g/l

0.17

406

1668

Psoriatic arthropathies

282

972

3.02

61.56

1.6

1.5

0.24

g/l

0.46

271

927

Other enthesopathies

743

3890

1.95

61.35

1.8

1.7

0.24

g/l

0.14

715

3701

436

1875

2.41

60.83

2.0

1.8

0.25

0.23

g/l

2.41

410

1788

Coxarthrosis

982

3534

1.82

60.81

1.7

1.5

0.24

g/l

0.37

938

3362

Other viral diseases, not elsewhere classified, including avohilmo

778

4131

1.92

60.64

2.1

1.8

0.23

g/l

0.32

742

3962

Other diseases of liver

528

2470

2.21

60.12

1.8

1.7

0.24

g/l

0.12

500

2359

Diaphragmatic hernia

882

4920

1.83

59.75

2.0

1.6

0.24

g/l

0.06

840

4681

Benign neoplasm of colon, rectum, anus and anal canal

1454

7768

1.61

59.67

1.7

1.6

0.24

g/l

0.00

1393

7388

Insulin, intermediate and long-acting

1268

7520

1.65

59.56

1.4

1.7

0.26

0.23

g/l

19.66

1209

7167

Cellulitis

600

2961

2.08

59.08

2.1

1.7

0.25

0.23

g/l

3.91

579

2819

Insulin, fast-acting or short human

910

5136

1.81

59.08

1.5

1.7

0.25

0.23

g/l

10.87

869

4901

Pain and other conditions associated with female genital organs and menstrual cycle

649

2724

2.05

59.02

2.0

1.9

0.22

0.23

g/l

0.49

615

2593

Cervicalgia

537

2542

2.17

58.98

1.7

1.8

0.23

g/l

0.53

515

2407

Peripheral arterial reconstruction

395

1645

2.48

58.94

1.4

0.25

0.23

g/l

2.49

380

1559

Obesity due to excess calories

1284

7963

1.64

58.85

1.6

1.9

0.26

0.23

g/l

38.33

1237

7616

ILD-related respiratory insufficiency

137

303

4.94

58.70

2.4

1.4

0.23

g/l

0.15

130

292

Coronary atherosclerosis

1360

5285

1.65

58.69

1.8

1.6

0.24

g/l

1.36

1303

5033

Iridocyclitis

612

3052

2.06

58.60

1.9

1.7

0.23

0.24

g/l

0.06

588

2911

Childhood asthma (age<16), excluding more controls

349

1044

2.68

58.57

2.0

0.22

g/l

0.02

330

1014

Migraine, single triptan purchase ok & required. ICD-code if available is included

1961

8937

1.51

58.31

1.9

0.23

g/l

2.27

1887

8545

Triptan medication for migraine, single purchase ok

1961

8937

1.51

58.31

1.9

0.23

g/l

2.27

1887

8545

Candidiasis

446

1977

2.34

58.16

2.0

1.9

0.23

g/l

0.10

427

1876

Meniscus derangement

1088

4214

1.74

58.03

1.6

0.24

g/l

0.26

1045

4009

Later onset COPD, excluding more controls

388

1195

2.53

57.90

1.4

0.24

g/l

0.97

369

1120

Carpal tunnel syndrome

1504

8369

1.58

57.87

1.6

1.8

0.24

g/l

0.10

1451

7977

Etanercept

249

835

3.17

57.76

1.6

1.8

0.22

0.23

g/l

1.24

234

792

Other or ill-defined heart diseases

169

440

4.04

57.73

2.1

1.6

0.23

0.24

g/l

0.71

159

421

Autoimmune hepatitis, wide definition

148

352

4.46

57.31

2.3

1.2

0.21

0.25

g/l

5.81

138

334

Childhood asthma (age<16)

349

1056

2.65

57.29

2.0

0.22

g/l

0.01

330

1026

Cervical disc disorders

830

4604

1.84

57.15

1.6

1.7

0.24

g/l

0.10

791

4391

Inflammatory diseases of the central nervous system

278

996

2.94

56.97

3.7

1.7

0.22

0.23

g/l

1.42

264

946

Dentofacial anomalies [including malocclusion]

1858

9780

1.51

56.71

1.9

0.23

g/l

1.44

1768

9356

Collagenous colitis

304

1146

2.79

56.50

1.9

1.8

0.24

0.23

g/l

0.13

288

1094

Diabetes mellitus

2487

10114

1.44

56.42

1.6

1.9

0.26

0.23

g/l

45.17

2381

9637

Disorders of choroid and retina

1849

8683

1.51

55.97

1.8

1.7

0.24

g/l

0.82

1772

8272

Diabetes, varying definitions

2473

10106

1.43

55.87

1.6

1.9

0.26

0.23

g/l

45.29

2368

9630

Internal derangement of knee

783

4253

1.85

55.57

1.8

1.7

0.24

g/l

0.05

746

4060

Chronic apical periodontitis

2715

10921

1.41

55.14

1.8

0.24

0.23

g/l

1.40

2606

10410

Primary biliary cholangitis, wide definition

160

6.51

55.07

1.8

1.2

0.21

0.24

g/l

3.58

151

Respiratory insufficiency

188

546

3.56

54.13

1.7

1.4

0.25

0.24

g/l

1.03

174

515

Pruritus

336

1356

2.57

54.01

2.1

1.9

0.23

g/l

0.32

318

1292

Stroke, excluding SAH

1303

5894

1.62

53.95

1.7

1.6

0.24

g/l

1.51

1243

5606

Drug-induced cataract

123

269

5.14

53.95

3.3

1.6

0.22

0.24

g/l

1.95

117

256

Benign neoplasm: Colon

1224

7171

1.63

53.85

1.7

1.6

0.24

g/l

0.05

1172

6815

Factors influencing health status and contact with health services

573

1356

2.15

53.67

1.6

1.5

0.24

g/l

0.04

546

1300

Cervicobrachial syndrome

567

2840

2.05

53.53

1.6

1.8

0.23

g/l

1.02

539

2697

COPD

927

4354

1.76

53.34

1.5

1.6

0.24

g/l

0.90

882

4115

Major coronary heart disease event excluding revascularizations

1235

5036

1.64

53.20

1.7

1.6

0.25

0.24

g/l

2.34

1176

4792

Amputation of toe

209

662

3.32

53.10

1.6

1.5

0.25

0.24

g/l

0.62

202

630

Senile cataract

1353

5192

1.61

52.65

1.8

1.6

0.24

g/l

0.22

1290

4953

Weight loss

306

1203

2.66

52.16

2.0

1.6

0.23

g/l

0.66

295

1143

Crohn disease

394

1737

2.35

52.08

1.7

1.9

0.24

0.23

g/l

0.28

374

1662

Stroke, including SAH

1369

6297

1.58

51.49

1.7

1.6

0.24

g/l

1.55

1305

5996

Deforming dorsopathies

676

3637

1.90

51.44

1.8

0.23

g/l

0.80

638

3461

Type 2 diabetes

2339

9595

1.43

51.33

1.6

1.8

0.26

0.23

g/l

46.35

2241

9142

Benzodiazepine use

2429

11751

1.41

51.30

1.7

1.8

0.23

g/l

0.29

2308

11232

Adrenocortical insufficiency

158

432

3.98

51.13

1.6

1.7

0.24

0.23

g/l

0.59

145

414

Pollen allergy

576

2911

2.01

51.07

1.7

2.0

0.22

0.23

g/l

0.11

546

2801

Disorders of parathyroid gland

511

2478

2.09

51.05

2.1

1.6

0.24

0.23

g/l

0.45

479

2340

Conjunctivitis (acute, non atopic)

761

4245

1.83

50.96

2.0

1.8

0.23

g/l

0.14

729

4066

Idiopathic gout

251

903

2.90

50.84

1.5

1.4

0.27

0.24

g/l

3.74

243

861

GI-bleeding

714

3926

1.85

50.63

1.7

1.6

0.24

g/l

0.19

672

3734

Sequelae with surgical and medical care as external cause

529

2641

2.06

50.62

1.7

0.24

0.23

g/l

1.23

505

2505

Use of hypnotics and sedatives

2534

10427

1.40

50.62

1.8

1.7

0.23

0.24

g/l

0.49

2421

9957

Sequelae of other external causes

201

642

3.32

50.61

1.6

1.7

0.25

0.24

g/l

0.73

190

612

Acute generalized exanthematous pustulosis

175

515

3.65

50.52

2.9

1.7

0.23

g/l

0.13

165

494

Other infectious diseases, including avohilmo

266

992

2.80

50.37

2.2

1.7

0.24

0.23

g/l

0.71

250

939

Phlebitis and thrombophlebitis (not including DVT)

575

2960

1.99

50.31

2.1

1.7

0.24

g/l

0.29

548

2813

Inflammatory diseases of female pelvic organs

1687

7779

1.51

50.21

2.0

1.9

0.23

g/l

0.56

1592

7432

Other viral diseases, not elsewhere classified

521

2590

2.06

50.00

2.1

1.8

0.23

g/l

0.17

497

2482

Enthesopathies of lower limb, excluding foot

570

2930

1.99

49.97

1.7

1.8

0.24

g/l

0.04

543

2792

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1216

6013

1.61

49.90

1.4

1.7

0.26

0.23

g/l

24.00

1161

5710

Sarcoidosis

374

1644

2.36

49.82

1.7

0.24

g/l

0.17

361

1570

Abnormal weight loss

283

1096

2.70

49.81

2.1

1.6

0.23

g/l

0.41

273

1044

Scleritis and episcleritis

230

804

3.04

49.64

2.3

1.9

0.25

0.23

g/l

1.18

214

764

Volume depletion

245

880

2.88

49.57

1.6

1.5

0.25

0.23

g/l

1.80

229

843

Abnormal results of function studies

278

1070

2.72

49.54

1.9

1.7

0.23

g/l

0.36

268

1018

Non-selective monoamine reuptake inhibitors

875

4927

1.74

49.30

1.6

1.7

0.24

0.23

g/l

1.41

826

4690

Coeliac disease

363

1589

2.37

48.87

2.3

1.9

0.21

0.23

g/l

7.07

346

1518

Ischaemic Stroke, excluding all haemorrhages

1197

5550

1.61

48.76

1.7

1.6

0.24

g/l

1.60

1138

5274

Disorders of muscles

277

1070

2.68

48.73

1.9

1.7

0.23

g/l

0.08

271

1009

Presence of other functional implants

1300

5704

1.58

48.54

1.7

1.6

0.24

g/l

0.01

1238

5414

Other encephalitis

128

313

4.49

48.48

5.2

1.6

0.21

0.23

g/l

2.44

122

302

Other infectious diseases

223

774

3.02

48.38

2.2

1.6

0.24

g/l

0.22

210

739

Other diseases of the digestive system

708

3942

1.83

48.24

1.7

1.6

0.24

g/l

0.00

667

3751

Other disorders of adrenal gland

179

551

3.48

48.17

1.6

1.7

0.24

0.23

g/l

0.54

166

525

Fall on same level

2772

10864

1.37

48.07

1.9

1.8

0.24

0.23

g/l

2.82

2642

10397

Herpesviral [herpes simplex] infections, including avohilmo

709

3969

1.83

47.78

2.1

1.8

0.23

g/l

1.41

681

3794

Hypokalaemia

326

1379

2.45

47.29

1.6

1.7

0.24

0.23

g/l

0.73

306

1314

Nonorganic sleeping disorders, excluding more controls

551

2860

1.97

47.03

2.0

1.8

0.23

g/l

0.04

527

2743

Trochanteric bursitis

378

1707

2.28

46.99

1.7

0.24

0.23

g/l

0.30

360

1607

Other disorders of eye and adnexa

426

2022

2.18

46.96

1.8

1.9

0.23

g/l

0.33

409

1919

Exposure to other specified factors

1986

12072

1.43

46.90

1.9

1.8

0.23

g/l

0.26

1905

11532

Statin medication

1620

6127

1.51

46.89

2.0

1.8

0.25

0.22

g/l

21.81

1555

5848

Dermatopolymyositis, unspecified

13.36

46.89

1.9

1.1

0.21

0.25

g/l

1.43

Other retinal disorders

1404

7038

1.53

46.81

1.8

1.6

0.24

g/l

1.07

1338

6690

Encephalitis

131

335

4.27

46.67

5.1

1.6

0.21

0.23

g/l

2.54

125

323

Anterior Iridocyclitis

532

2743

1.99

46.49

1.9

1.8

0.23

0.24

g/l

0.38

509

2617

Unspecified acute lower respiratory infection

406

1899

2.20

46.26

1.8

1.7

0.24

g/l

0.35

386

1811

Osteomyelitis

197

656

3.16

46.11

1.8

1.5

0.25

0.24

g/l

0.90

192

630

Other inflammation of eyelid, including avohilmo

1142

7305

1.59

45.96

2.1

1.8

0.23

g/l

0.75

1091

6970

Other diseases of anus and rectum

692

3869

1.82

45.92

1.8

1.6

0.23

g/l

0.11

656

3671

Myocardial infarction

961

4060

1.68

45.75

1.7

1.6

0.24

g/l

2.20

919

3860

Other disorders of veins

1003

6135

1.64

45.52

1.7

0.23

0.24

g/l

0.10

959

5832

Diseases of the ear and mastoid process

2739

10142

1.37

45.48

1.9

1.8

0.23

g/l

0.93

2610

9698

Acute and subacute iridocyclitis

497

2528

2.02

45.18

1.9

1.7

0.23

0.24

g/l

0.28

475

2412

Other external causes of accidental injury

1883

6548

1.46

45.01

1.9

1.8

0.24

0.23

g/l

1.44

1795

6283

Disorders of mineral metabolism

248

946

2.73

44.97

1.7

0.25

0.23

g/l

1.36

236

914

Agranulocytosis

325

1410

2.40

44.78

2.7

1.7

0.21

0.23

g/l

5.69

306

1347

Generalized skin eruption due to drugs and medicaments

152

446

3.66

44.16

3.1

1.7

0.23

0.24

g/l

0.42

142

427

Abnormalities of gait and mobility

317

1369

2.40

43.99

1.6

1.5

0.23

0.24

g/l

0.16

306

1306

Unspecified privation

306

1306

2.43

43.72

1.8

1.7

0.23

g/l

0.12

293

1241

Atopic dermatitis, strict definition

820

4792

1.71

43.60

1.8

2.0

0.23

g/l

0.13

785

4607

Monoarthritis, not elsewhere classified

130

346

3.97

43.28

1.3

1.6

0.23

0.24

g/l

0.62

124

331

Chronic diseases of tonsils and adenoids

1829

8094

1.44

43.27

1.8

0.23

g/l

1.43

1750

7757

Other disorders of patella

391

1848

2.17

43.23

1.8

1.7

0.23

0.24

g/l

0.47

370

1764

Benign neoplasms

2279

8998

1.39

43.14

1.9

1.8

0.23

g/l

0.01

2167

8630

Disorders of gallbladder, biliary tract and pancreas

2299

10441

1.38

43.10

1.8

1.7

0.24

0.23

g/l

8.26

2191

9967

Other chronic obstructive pulmonary disease

857

4213

1.69

43.09

1.5

1.6

0.24

g/l

0.97

815

3984

Erythema multiforme

107

250

4.72

43.08

2.8

1.5

0.21

0.23

g/l

1.72

101

241

Recurrent aphthous stomatitis , including avohilmo

408

1975

2.13

42.71

2.1

1.8

0.22

0.23

g/l

1.75

387

1882

Other diseases of intestine

380

1789

2.18

42.58

1.7

1.6

0.24

g/l

0.45

365

1697

Other dermatomyositis

13.00

42.50

1.6

1.1

0.20

0.25

g/l

2.85

Stomatitis and related lesions

537

2872

1.92

42.09

2.0

1.8

0.22

0.23

g/l

1.83

506

2741

Hallux valgus (acquired)

660

2633

1.82

42.07

1.8

1.6

0.23

0.24

g/l

3.04

623

2499

Conduction disorders

596

2604

1.86

41.82

1.6

0.23

0.24

g/l

0.23

560

2453

Psoriasis

684

3941

1.77

41.73

1.6

1.7

0.25

0.23

g/l

5.74

656

3755

Presence of cardiac and vascular implants and grafts

869

3867

1.68

41.71

1.7

1.5

0.24

g/l

0.45

818

3664

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

137

390

3.77

41.66

2.4

1.5

0.22

0.24

g/l

2.02

131

369

Selective serotonin reuptake inhibitors

2251

8511

1.39

41.62

1.8

0.24

0.23

g/l

2.52

2147

8128

Accidents

1859

6548

1.44

41.53

1.9

1.8

0.24

0.23

g/l

1.78

1774

6283

Herpesviral [herpes simplex] infections

337

1532

2.28

41.50

2.1

1.7

0.23

g/l

0.82

323

1454

IBD patients in KELA-register

584

3224

1.85

41.26

1.6

1.8

0.23

g/l

0.84

555

3089

Adjustment and management of implanted device

389

1870

2.13

41.17

1.5

0.24

0.23

g/l

0.60

364

1769

Disorders of calcium metabolism

193

679

2.98

40.98

1.7

1.6

0.24

0.23

g/l

0.77

183

656

Valvular operations

289

1233

2.40

40.94

1.7

1.4

0.24

g/l

0.13

275

1164

Exclusions for E4_PCOS_BROAD

473

2448

1.99

40.90

1.8

0.24

0.23

g/l

0.59

450

2340

Suggestive for eosinophilic asthma

251

1010

2.58

40.82

1.6

1.7

0.24

g/l

0.14

245

960

Angina pectoris

1101

4702

1.57

40.18

1.7

1.6

0.24

g/l

1.71

1052

4475

Amyloidosis

205

4.94

40.11

1.6

0.24

0.23

g/l

0.47

198

Oxicams

497

1433

2.00

40.04

1.9

1.8

0.23

0.24

g/l

0.90

480

1362

All influenza (not pneumonia)

358

1687

2.18

40.01

1.9

1.6

0.23

g/l

0.56

337

1608

Other cataract

944

4391

1.62

39.76

2.1

1.6

0.24

g/l

0.08

898

4180

Pacemaker

721

3954

1.72

39.68

1.4

1.5

0.23

0.24

g/l

0.18

672

3741

Ulcerative colitis

603

3404

1.81

39.54

1.6

1.8

0.23

0.24

g/l

0.63

567

3256

Ocular pain

271

1149

2.46

39.50

1.8

1.9

0.24

0.23

g/l

0.32

260

1090

Diplopia

352

1662

2.19

39.38

1.7

0.23

0.24

g/l

0.77

341

1577

Psychiatric diseases

2190

8007

1.38

39.36

1.8

0.24

0.23

g/l

0.18

2100

7646

Ulcerative colitis, NAS

376

1823

2.13

39.20

1.6

1.8

0.22

0.23

g/l

1.65

354

1744

Obesity, other/unspecified

883

5531

1.63

39.14

1.7

1.9

0.26

0.23

g/l

23.55

837

5299

Lichen simplex chronicus and prurigo

180

625

3.01

39.14

1.5

1.7

0.24

g/l

0.24

169

598

Other symptoms and signs involving cognitive functions and awareness

1021

5834

1.57

38.99

1.8

1.6

0.23

0.24

g/l

0.97

949

5566

Missing teeth due to accident, extraction or parodontitis

1378

8451

1.47

38.89

1.8

1.7

0.23

0.24

g/l

0.84

1319

8049

Other erythematous conditions

128

366

3.74

38.66

2.2

1.6

0.24

g/l

0.26

123

352

Drug-induced adrenocortical insufficiency

100

243

4.63

38.61

1.8

1.6

0.24

g/l

0.12

235

Misadventures to patients during surgical and medical care

376

1838

2.11

38.35

1.8

0.25

0.23

g/l

2.17

353

1754

Persons encountering health services for specific procedures, not carried out

255

1065

2.49

38.30

1.6

1.9

0.24

0.23

g/l

0.74

240

1012

Paracetamol or NSAID medication

344

764

2.31

38.18

1.5

1.9

0.23

g/l

0.73

335

735

Crohn's disease NAS

205

774

2.78

38.18

1.7

1.8

0.24

0.23

g/l

0.55

196

738

Injuries to the ankle and foot

1764

10865

1.40

37.58

1.9

1.8

0.23

g/l

0.33

1685

10393

Inflammatory bowel disease, strict (require KELA)

584

3317

1.80

37.58

1.6

1.8

0.23

g/l

0.77

555

3177

Irregular menses

1298

6640

1.49

37.45

2.3

1.9

0.23

g/l

0.40

1241

6342

Pneumonia due to other infectious organisms, not elsewhere classified

116

317

3.90

37.43

2.1

1.5

0.24

g/l

0.12

109

304

Special screening examination for infectious and parasitic diseases

535

2121

1.87

37.28

2.0

1.7

0.23

0.24

g/l

2.33

509

2051

Other symptoms and signs involving the circulatory and respiratory systems

182

655

2.89

36.94

2.1

1.5

0.23

g/l

0.05

171

626

Radiculopathy

359

1747

2.10

36.88

1.6

1.7

0.24

g/l

0.29

344

1655

Other embolism and thrombosis

320

1498

2.20

36.56

2.4

1.7

0.24

g/l

0.22

305

1421

Viral and other specified intestinal infections, including avohilmo

695

4007

1.70

36.47

2.0

1.9

0.23

g/l

0.79

663

3856

Allergic contact dermatitis

341

1642

2.14

36.19

1.6

1.8

0.24

0.23

g/l

1.00

323

1565

Hyperkinetic disorders, excluding more controls

357

1624

2.10

36.11

1.7

2.0

0.22

g/l

0.48

340

1566

Other disorders of bone

492

2688

1.87

36.09

1.8

0.24

0.23

g/l

0.16

467

2565

Gastroduodenal ulcer

519

2867

1.84

36.05

1.7

1.6

0.24

g/l

0.28

489

2728

Keratitis

839

5294

1.61

36.02

2.0

1.8

0.23

g/l

0.05

797

5057

Non-invasive ventilation

495

2319

1.87

35.80

1.6

1.7

0.25

0.22

g/l

8.32

438

2223

Coxibs

576

1664

1.84

35.75

1.7

1.9

0.23

g/l

0.33

546

1588

Cardiomyopathy, other and unspecified

185

684

2.80

35.65

1.7

1.5

0.24

g/l

0.23

173

648

Abnormal findings on diagnostic imaging of other body structures

364

1807

2.07

35.62

1.8

1.7

0.24

g/l

0.07

349

1720

Osteonecrosis

186

694

2.81

35.48

2.6

1.5

0.24

g/l

0.00

181

662

Other inflammatory liver diseases

193

734

2.75

35.43

2.2

1.7

0.22

0.24

g/l

3.46

182

700

Calcific aortic valvular stenosis, diagnosis (helper)

559

3059

1.79

35.40

1.6

1.5

0.23

g/l

0.13

531

2884

Operations 2 for CAVS

559

3059

1.79

35.40

1.6

1.5

0.23

g/l

0.13

531

2884

Other inflammation of eyelid

370

1852

2.06

35.39

2.2

1.6

0.23

0.24

g/l

1.00

347

1751

Calcific aortic valvular stenosis, including rheumatic fever

561

3076

1.78

35.15

1.6

1.5

0.23

g/l

0.11

533

2901

Other and unspecified disorders of skin and subcutaneous tissue

179

658

2.84

35.09

2.4

1.6

0.22

0.23

g/l

1.74

170

629

Other shoulder lesions

247

1058

2.41

34.99

1.9

1.8

0.24

0.23

g/l

0.30

233

997

Neoplasms

1775

6710

1.40

34.92

1.9

1.8

0.23

g/l

0.23

1697

6462

Calcific aortic valvular stenosis, operated

559

3074

1.78

34.82

1.6

1.5

0.23

g/l

0.13

531

2898

Calcific aortic valvular stenosis

559

3074

1.78

34.82

1.6

1.5

0.23

g/l

0.13

531

2898

Chronic laryngitis and laryngotracheitis

348

1714

2.09

34.78

1.9

1.8

0.23

g/l

0.66

329

1638

Falls/tendency to fall

2487

9452

1.33

34.75

1.9

1.8

0.24

0.23

g/l

2.33

2373

9052

AV-block

333

1360

2.13

34.65

1.5

0.24

g/l

0.11

311

1282

Other symptoms and signs involving the digestive system and abdomen

406

2111

1.97

34.65

2.0

1.7

0.23

g/l

0.66

382

2020

External causes of morbidity and mortality

1455

5071

1.45

34.61

1.9

1.8

0.23

g/l

0.70

1389

4881

Other and unspecified erythematous conditions

117

340

3.68

34.56

2.2

1.6

0.24

g/l

0.25

112

327

Injury, poisoning and certain other consequences of external causes

1200

4030

1.51

34.48

1.9

1.8

0.23

g/l

0.03

1146

3867

Myocardial infarction, strict

843

3754

1.61

34.46

1.7

1.6

0.25

0.24

g/l

2.72

805

3567

Cytomegaloviral disease, including avohilmo

104

281

4.04

34.46

2.5

1.6

0.25

0.24

g/l

0.45

269

Acute nephritic syndrome

219

4.50

34.41

2.4

1.4

0.25

0.24

g/l

0.70

209

Cardiomyopathies, Primary/intrinsic

248

1070

2.38

34.40

1.5

1.4

0.24

g/l

0.13

228

1013

Haemorrhage, not elsewhere classified

100

260

4.02

34.37

2.2

1.6

0.23

g/l

0.06

250

Injuries to the knee and lower leg

2758

11514

1.30

34.35

1.8

0.24

0.23

g/l

1.56

2649

10974

Type 2 diabetes, definitions combined

2116

9180

1.35

34.29

1.6

1.8

0.26

0.23

g/l

44.45

2028

8749

Protozoal diseases

116

338

3.71

34.27

2.0

1.5

0.23

0.24

g/l

0.04

109

324

Vascular disorders of the intestines

170

614

2.87

34.26

1.9

1.5

0.24

g/l

0.01

161

577

Cytomegaloviral disease

103

279

4.03

34.02

2.5

1.6

0.25

0.24

g/l

0.48

267

COPD, hospital admission 2, with asthma infections

630

3212

1.72

33.90

1.6

0.24

g/l

0.86

595

3046

Chronic tubulo-interstitial nephritis

117

343

3.60

33.90

1.6

1.9

0.25

0.23

g/l

1.58

112

330

Type 2 diabetes, strict (exclude DM1)

2125

9245

1.35

33.82

1.6

1.8

0.26

0.23

g/l

44.83

2037

8814

Nonalcoholic fatty liver disease

289

1344

2.23

33.82

1.7

1.8

0.24

g/l

0.51

275

1283

Pneumocystosis

210

4.59

33.76

2.0

1.4

0.24

0.23

g/l

0.41

200

Pneumocystosis, including avohilmo

210

4.59

33.76

2.0

1.4

0.24

0.23

g/l

0.41

200

Viral warts

278

1274

2.26

33.69

2.9

1.8

0.22

0.23

g/l

2.16

270

1207

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2082

9230

1.35

33.37

1.5

1.8

0.26

0.23

g/l

40.97

1990

8801

Non-Hodgkin lymphoma, all, including Hilmo

301

1426

2.17

33.37

1.8

1.6

0.22

0.24

g/l

1.29

277

1353

Diseases of pulp and periapical tissues, including avohilmo

2370

9305

1.33

33.22

1.8

0.24

0.23

g/l

2.24

2268

8882

Other Crohn's disease

210

859

2.55

33.20

1.8

0.24

0.23

g/l

0.38

199

818

Other medical care

1019

5698

1.52

33.18

1.5

1.7

0.24

0.23

g/l

0.79

984

5412

Cardiomyopathy (excluding other)

255

1132

2.31

33.11

1.5

1.4

0.24

g/l

0.06

235

1072

Other specified/unspecified soft tissue disorders

135

438

3.22

33.10

2.1

1.7

0.24

0.23

g/l

0.20

130

413

Neuralgia and neuritis, unspecified

149

513

3.04

32.98

1.7

0.23

g/l

0.05

142

481

Iron deficiency anaemia secondary to blood loss (chronic)

368

1885

2.00

32.88

1.7

1.6

0.23

0.24

g/l

0.42

351

1778

Nonsuppurative otitis media, including avohilmo

786

4295

1.61

32.83

2.1

1.9

0.23

g/l

0.25

761

4121

Scleritis

158

5.21

32.62

1.9

1.4

0.24

g/l

0.19

152

Multiple myeloma, including Hilmo

130

417

3.28

32.60

1.7

0.24

0.23

g/l

0.23

121

396

Protozoal diseases, including avohilmo

116

350

3.56

32.45

2.0

1.5

0.23

0.24

g/l

0.06

109

335

Localized swelling, mass and lump of skin and subcutaneous tissue

719

4489

1.63

32.35

2.0

1.7

0.23

0.24

g/l

1.58

692

4276

Polyuria

491

2771

1.81

32.32

1.9

1.6

0.23

0.24

g/l

1.22

465

2637

Other diseases of oesophagus

227

971

2.41

32.27

2.2

1.5

0.23

0.24

g/l

1.59

218

928

Cytomegalovirus infection, IBD co-morbidity

100

276

3.96

32.19

2.5

1.6

0.25

0.24

g/l

0.55

264

Diabetic retinopathy, excluding more controls

590

1907

1.77

32.16

1.4

1.7

0.26

0.25

g/l

0.94

568

1834

Other metabolic disorders

357

1827

2.01

32.14

1.6

1.9

0.24

0.23

g/l

2.07

338

1744

Crohn's disease of small intestine

206

851

2.52

31.89

1.7

1.9

0.23

g/l

0.40

199

810

Other hammer toe(s) (acquired)

327

1466

2.07

31.87

1.7

1.5

0.22

0.24

g/l

2.58

315

1394

Type 1 diabetes

572

3379

1.72

31.80

1.7

1.8

0.24

0.22

g/l

6.02

541

3227

Type 2 diabetes, definitions combined, including avohilmo

2119

9246

1.34

31.67

1.6

1.8

0.26

0.23

g/l

44.25

2031

8815

Sequelae of cerebrovascular disease

713

3791

1.63

31.59

2.0

1.6

0.24

0.23

g/l

0.76

682

3594

Disorders of vitreous body

1102

7201

1.47

31.52

1.7

0.24

g/l

0.29

1044

6856

Disorders of vitreous body and globe

1125

7336

1.47

31.50

1.7

0.24

g/l

0.29

1066

6990

Injuries to the thorax

979

6573

1.51

31.49

1.7

0.24

g/l

0.44

930

6263

Open wound of lower leg

378

1985

1.95

31.46

2.2

1.7

0.23

0.24

g/l

0.22

362

1886

Other chronic obstructive pulmonary disease, including avohilmo

1062

5922

1.49

31.44

1.6

0.24

g/l

0.91

1011

5626

Other/unspecified synovitis and tenosynovitis

274

1282

2.20

31.38

2.1

1.7

0.22

0.23

g/l

1.02

264

1209

Hypotension

358

1848

1.98

31.20

1.7

1.5

0.24

g/l

0.86

337

1749

Other and unspecified disorders of white blood cells

131

435

3.19

31.14

2.3

1.6

0.22

0.24

g/l

1.83

121

415

Haemorrhoids and perianal venous thrombosis

710

4425

1.62

31.09

1.6

0.23

0.24

g/l

0.57

687

4197

Injuries to the abdomen, lower back, lumbar spine and pelvis

902

5888

1.53

31.08

1.9

1.7

0.23

g/l

0.22

859

5602

Other psoriatic arthropathies

273

1284

2.20

31.06

1.6

1.7

0.25

0.24

g/l

0.79

262

1218

Hyperparathyroidism

401

2129

1.90

31.06

1.9

1.6

0.24

0.23

g/l

1.02

373

2016

Algoneurodystrophy

123

395

3.33

31.06

1.6

0.23

0.24

g/l

0.21

118

373

Episcleritis

177

692

2.69

30.96

2.3

1.9

0.25

0.23

g/l

1.26

165

656

Diseases of tongue

168

639

2.73

30.77

2.2

1.6

0.23

0.24

g/l

0.16

157

606

Gastric ulcer

355

1837

1.97

30.71

1.7

1.6

0.23

0.24

g/l

0.16

332

1741

Hypoparathyroidism

124

403

3.27

30.65

2.7

1.7

0.23

g/l

0.22

116

385

Bullous disorders

158

585

2.82

30.62

1.8

1.6

0.22

0.23

g/l

0.57

151

557

DVT of lower extremities

412

2243

1.88

30.59

2.2

1.6

0.24

g/l

0.51

391

2127

Multiple myeloma and malignant plasma cell neoplasms

133

449

3.11

30.59

1.8

1.5

0.24

g/l

0.01

123

430

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

135

462

3.11

30.56

1.8

1.6

0.24

0.23

g/l

0.58

119

436

Psoriatic arthropathies, ICD10

279

1332

2.17

30.55

1.6

1.7

0.24

g/l

0.72

268

1265

Other/unspecified reactive arthropathies

193

791

2.55

30.47

2.8

1.8

0.23

g/l

0.13

187

754

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1525

10149

1.38

30.46

1.8

1.9

0.23

g/l

0.13

1467

9690

Myocardial infarction, without ST-elevation

744

4267

1.59

30.43

1.6

1.5

0.24

g/l

1.96

710

4045

Ovarian cyst

848

3123

1.58

30.42

1.9

1.8

0.23

g/l

0.04

809

2966

COPD related to multimorbidity

748

4017

1.60

30.36

1.5

1.6

0.24

g/l

1.34

712

3808

Cirrhosis of liver, NAS

152

555

2.87

30.29

1.3

1.6

0.20

0.24

g/l

4.86

143

532

Diseases of middle ear and mastoid

1355

7919

1.41

30.22

1.9

0.23

g/l

0.65

1297

7585

Sacroiliitis, not elsewhere classified

148

534

2.90

30.14

1.7

2.0

0.24

0.23

g/l

0.49

140

503

Metatarsalgia

242

1097

2.27

30.08

2.0

1.8

0.23

g/l

0.31

232

1037

Viral warts, including avohilmo

543

3226

1.72

29.87

2.5

1.7

0.22

0.23

g/l

3.03

517

3087

Paralytic ileus and intestinal obstruction

518

3031

1.73

29.84

1.5

1.6

0.24

g/l

0.05

491

2867

Nonorganic sleeping disorders

551

3288

1.71

29.84

2.0

1.9

0.23

g/l

0.03

527

3146

COPD, early/later onset

863

4770

1.54

29.81

1.5

1.6

0.24

g/l

0.70

821

4530

COPD, hospital admissions 3, with asthma pneumonia sepsis

513

2552

1.75

29.75

1.6

1.5

0.24

g/l

0.70

484

2424

Endometriosis

816

3047

1.58

29.72

1.8

0.23

g/l

0.22

779

2891

Epilepsy

639

3943

1.64

29.71

2.1

1.7

0.23

g/l

0.62

602

3770

Seborrhoeic dermatitis

231

1033

2.30

29.65

2.0

1.7

0.22

0.24

g/l

2.85

221

986

Complications of internal orthopaedic prosthetic devices, implants and grafts

466

2657

1.79

29.64

1.7

1.6

0.24

g/l

0.19

440

2502

Nonischemic cardiomyopathy

223

982

2.34

29.61

1.9

1.6

0.23

0.24

g/l

0.20

208

934

Disorders of ocular muscles, binocular movement, accommodation and refraction

1151

8010

1.44

29.51

1.9

1.8

0.23

g/l

0.22

1082

7662

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

330

1693

2.00

29.48

1.4

1.6

0.21

0.24

g/l

5.46

312

1612

Other enthesopathy of foot (+metatarsalgia)

258

1210

2.19

29.45

2.0

1.8

0.23

g/l

0.10

248

1143

Other local infections of skin and subcutaneous tissue

264

1252

2.17

29.35

2.2

1.7

0.24

0.23

g/l

0.19

247

1191

Benign neoplasm of other and ill-defined parts of digestive system

413

2288

1.85

29.12

1.6

1.7

0.24

g/l

0.37

391

2169

COPD, hospital admissions

852

4742

1.53

29.02

1.5

1.6

0.24

g/l

0.75

811

4503

Arthropathic psoriasis

287

1413

2.09

28.92

1.6

1.7

0.25

0.24

g/l

1.32

275

1343

Other and unspecified myopathies

203

869

2.41

28.90

1.4

1.5

0.24

g/l

0.05

193

826

Other CVD

410

2268

1.84

28.86

1.7

1.5

0.25

0.24

g/l

1.59

386

2145

Personality disorders, excluding more controls

587

3582

1.66

28.75

1.8

1.9

0.24

0.23

g/l

0.73

554

3434

Disease of hard tissues of teeth, NOS

1088

3893

1.48

28.73

1.8

1.6

0.23

0.24

g/l

0.16

1033

3690

Cerebral palsy and other paralytic syndromes

282

1383

2.10

28.68

2.1

1.7

0.24

0.23

g/l

0.68

265

1316

Other and unspecified local infections of skin and subcutaneous tissue

251

1181

2.19

28.51

2.2

1.7

0.24

0.23

g/l

0.47

234

1127

Crohn disease (strict definition, require KELA, min 2 HDR)

191

804

2.48

28.47

1.8

1.9

0.23

g/l

0.06

185

759

Emphysema

164

640

2.64

28.47

1.7

1.5

0.23

0.24

g/l

0.38

156

602

Adhesive capsulitis of shoulder

353

1873

1.92

28.44

1.6

0.24

g/l

0.67

339

1773

Diabetic maculopathy, excluding more controls

251

1181

2.18

28.42

1.4

1.7

0.26

0.23

g/l

6.55

242

1119

Other/unspecified cytomegaloviral diseases

243

3.97

28.41

2.5

1.5

0.25

0.24

g/l

0.60

231

Pneumonia derived septicemia

111

353

3.33

28.39

3.1

1.4

0.23

0.24

g/l

0.69

103

335

Acute pharyngitis

364

1933

1.90

28.31

1.9

1.8

0.24

0.23

g/l

0.69

347

1859

Amputation of foot

242

3.89

28.28

1.4

0.24

g/l

0.05

232

Retention of urine

659

3338

1.62

28.24

1.5

1.6

0.24

g/l

0.15

611

3171

Ankylosing spondylitis

216

960

2.32

28.21

1.7

0.23

0.24

g/l

0.52

206

915

Psoriasis vulgaris

427

2413

1.81

28.14

1.5

1.7

0.26

0.24

g/l

5.40

410

2293

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

796

5257

1.54

28.10

1.8

0.23

g/l

0.20

756

5017

Problems related to lifestyle

266

1286

2.13

28.08

1.8

1.7

0.24

0.23

g/l

0.20

260

1223

Cervicocranial syndrome

258

1233

2.15

28.05

1.5

1.8

0.23

g/l

0.30

248

1167

Behavioural syndromes associated with physiological disturbances and physical factors

2154

11261

1.30

27.97

1.8

0.23

g/l

0.62

2074

10742

Congenital malformations, deformations and chromosomal abnormalities

1378

9531

1.38

27.96

1.7

1.9

0.23

g/l

0.48

1325

9107

Brachial plexus disorders

257

1231

2.16

27.94

1.6

2.0

0.23

g/l

0.11

252

1167

Dermatophytosis

328

1712

1.97

27.92

2.0

1.6

0.23

0.24

g/l

1.39

319

1626

Heartburn

270

1315

2.11

27.91

1.6

0.24

g/l

0.12

256

1261

Other extrapyramidal and movement disorders in other diseases

557

3392

1.67

27.89

1.7

0.23

g/l

0.74

530

3217

Diseases of oral cavity, salivary glands and jaws

1114

3964

1.46

27.76

1.7

1.6

0.24

g/l

0.01

1054

3754

Lichen ruber planus, wide definition including periferal and oral lichen planus

521

3124

1.70

27.76

1.7

0.23

0.24

g/l

0.58

497

2970

Covid-19 suspected case

530

3192

1.69

27.74

2.0

1.9

0.23

g/l

0.26

514

3048

Post-traumatic stress disorder

254

1215

2.16

27.69

1.6

2.1

0.23

0.22

g/l

0.90

241

1160

Crohn disease (strict definition, require KELA)

192

821

2.44

27.64

1.8

1.9

0.23

g/l

0.04

186

776

Postprocedural disorders of nervous system

219

991

2.30

27.61

2.2

2.1

0.23

g/l

0.01

209

942

Excessive, frequent and irregular menstruation

916

3262

1.52

27.61

2.2

1.9

0.23

g/l

0.23

874

3103

Nonsuppurative otitis media

558

2939

1.68

27.59

1.9

2.0

0.23

g/l

0.26

540

2815

Hernia

2053

10499

1.31

27.39

1.8

1.7

0.24

g/l

0.03

1949

10034

Erythema nodosum

302

3.49

27.17

2.1

1.7

0.24

g/l

0.03

288

Dental caries, including avohilmo

1501

5621

1.38

27.00

1.7

0.23

g/l

0.18

1437

5342

COPD-related respiratory insufficiency

243

1152

2.16

26.97

1.4

1.5

0.24

g/l

0.16

224

1098

Oter anti-inflammatory and antirheumatic agents, non-steroids

420

1265

1.85

26.96

1.6

1.7

0.23

0.24

g/l

0.39

396

1201

Amyloidosis, other/unspecified

187

4.29

26.92

1.3

1.6

0.24

0.23

g/l

0.53

181

Systemic disorders of connective tissue in diseases classified elsewhere

10.66

26.88

1.5

1.1

0.23

g/l

0.16

Nummular dermatitis

188

805

2.41

26.78

1.4

1.6

0.24

g/l

0.11

181

769

Transient ischemic attack

1016

5622

1.46

26.71

1.8

1.6

0.24

g/l

0.01

959

5343

Viral infections of the central nervous system

198

872

2.36

26.59

2.7

1.8

0.22

0.23

g/l

0.59

184

826

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

199

879

2.35

26.58

1.8

1.9

0.23

g/l

0.01

192

832

Abnormal involuntary movements

324

1715

1.94

26.47

1.8

1.7

0.23

g/l

0.19

302

1629

Spondylolisthesis/Spondylolysis

391

2193

1.82

26.41

1.8

1.7

0.23

0.24

g/l

0.64

372

2080

Abnormal findings on diagnostic imaging of central nervous system

150

585

2.68

26.36

1.7

1.8

0.24

g/l

0.01

145

553

Prurigo nodularis

221

3.91

26.33

1.4

1.7

0.24

g/l

0.28

214

Impingement syndrome of shoulder

466

2748

1.72

26.32

1.8

1.6

0.23

0.24

g/l

0.81

450

2607

Golimumab

118

407

3.06

26.30

1.7

1.8

0.22

0.24

g/l

1.23

113

388

Other diseases of blood and blood-forming organs

178

752

2.46

26.28

2.0

1.6

0.24

g/l

0.07

164

718

Other follicular disorders

212

966

2.27

26.23

1.6

1.9

0.24

0.23

g/l

0.21

201

918

Fracture of rib(s), sternum and thoracic spine

629

4002

1.60

26.22

1.7

1.6

0.24

g/l

0.55

600

3805

Substance abuse, excluding more controls

1147

6836

1.42

26.20

1.7

0.24

g/l

2.26

1090

6556

Disorders of vestibular function (Vertigo)

1007

6869

1.45

26.17

1.7

0.24

0.23

g/l

0.47

971

6525

Corns and callosities

166

681

2.53

26.10

2.1

1.5

0.23

0.24

g/l

1.00

158

653

Abnormal serum enzyme levels

567

3396

1.63

26.05

1.8

1.5

0.24

g/l

0.01

542

3243

Superficial injury of lower leg

621

3951

1.60

25.97

1.7

1.8

0.24

0.23

g/l

1.60

588

3766

Other and unspecified tonsillitis

742

4053

1.54

25.96

1.7

1.9

0.24

0.23

g/l

1.59

709

3899

Suppurative and unspecified otitis media

851

5109

1.49

25.94

1.9

2.0

0.23

g/l

0.02

812

4905

Other/unspecified enthesopathies of lower limb, excluding foot

192

843

2.35

25.91

1.5

1.8

0.24

0.23

g/l

0.05

185

805

Polycystic ovarian syndrome, consortium definition

1757

7633

1.33

25.90

2.2

1.9

0.23

g/l

0.26

1674

7277

Infective dermatitis

245

1184

2.12

25.89

1.7

0.24

g/l

0.16

230

1125

Artrosis, including avohilmo

1784

7402

1.33

25.79

1.7

1.8

0.24

g/l

0.22

1708

7046

Postprocedural endocrine and metabolic disorders, not elsewhere classified

319

1696

1.93

25.76

1.6

1.9

0.24

0.23

g/l

2.11

301

1620

Sleep disorders

2066

11060

1.30

25.76

1.7

1.8

0.23

g/l

0.54

1985

10548

Neuromuscular dysfunction of bladder

214

986

2.24

25.65

2.0

1.6

0.23

0.24

g/l

0.23

195

945

Generalized anxiety disorder

415

2388

1.77

25.59

1.7

2.0

0.23

g/l

0.15

396

2295

Injuries to the head

2525

11910

1.27

25.51

1.8

0.24

0.23

g/l

0.62

2420

11368

Cluster headache, wide

115

398

3.03

25.37

1.9

1.8

0.23

0.24

g/l

0.60

110

378

Diabetes, insulin treatment (Kela reimbursement)

2189

10190

1.29

25.33

1.5

1.8

0.26

0.23

g/l

36.27

2093

9727

Type 1 diabetes, wide definition, subgroup 1

471

2815

1.70

25.28

1.5

1.8

0.24

0.22

g/l

4.18

444

2691

Other diseases of hard tissues of teeth

1090

3956

1.44

25.27

1.7

1.6

0.24

g/l

0.15

1034

3747

Cerebral cysts

164

681

2.51

25.22

1.7

1.8

0.22

0.23

g/l

1.55

158

650

Vitreous haemorrhage

235

1132

2.14

25.15

1.4

1.6

0.25

0.24

g/l

1.40

222

1073

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

850

3616

1.50

25.12

2.7

2.1

0.22

0.23

g/l

1.52

822

3456

Other bursopathies

274

1395

2.01

25.05

1.8

1.6

0.24

g/l

0.02

261

1311

Unspecified fall

1111

7832

1.41

25.00

1.7

0.24

0.23

g/l

0.71

1050

7474

Lesion of ulnar nerve

314

1676

1.92

24.99

1.7

0.23

0.24

g/l

0.94

305

1604

Viral infections of the central nervous system, including avohilmo

210

975

2.23

24.84

2.6

1.7

0.22

0.23

g/l

0.94

196

925

Mucosal proctocolitis

312

1667

1.92

24.81

1.6

1.9

0.23

0.24

g/l

0.79

293

1591

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

239

1167

2.11

24.72

1.7

0.24

g/l

0.02

225

1110

Deviated nasal septum

642

4157

1.56

24.63

1.6

1.7

0.25

0.24

g/l

1.08

609

3978

Acute laryngitis and tracheitis

284

1451

1.97

24.49

2.1

1.9

0.23

g/l

0.62

271

1398

Diseases of pulp and periapical tissues and dental caries

1329

4972

1.38

24.39

1.8

1.7

0.24

0.23

g/l

0.64

1270

4720

Disturbance of activity and attention

359

1964

1.83

24.35

1.7

2.0

0.22

g/l

0.44

343

1888

Cluster headache, strict

110

381

3.03

24.28

1.9

1.8

0.23

0.24

g/l

0.58

105

362

Fenamates

316

1133

1.93

24.27

1.8

2.0

0.23

g/l

0.15

303

1076

Other obstetric conditions, not elsewhere classified

862

3711

1.49

24.25

2.6

2.0

0.22

0.23

g/l

1.63

833

3547

Early onset COPD

450

2691

1.70

24.24

1.7

0.24

g/l

0.30

428

2566

Trigeminal neuralgia

158

658

2.49

24.13

1.6

1.7

0.24

g/l

0.00

149

624

Injuries to the wrist and hand

2295

12089

1.27

23.83

1.7

1.8

0.23

g/l

0.03

2186

11551

Chronic iridocyclitis

140

555

2.63

23.83

2.1

1.6

0.22

0.23

g/l

0.67

134

526

Fissure and fistula of anal and rectal regions

500

3087

1.64

23.72

1.7

0.24

0.23

g/l

0.48

474

2927

Acute suppurative otitis media

632

3836

1.56

23.62

2.0

0.23

g/l

0.18

607

3693

Infections with a predominantly sexual mode of transmission

739

4979

1.50

23.52

2.3

1.9

0.22

0.23

g/l

1.61

701

4788

Supplementary factors related to causes of morbidity and mortality classified elsewhere

690

4596

1.52

23.45

1.9

1.8

0.23

g/l

0.01

656

4374

Viral and other specified intestinal infections

473

2816

1.66

23.44

2.0

1.9

0.23

g/l

0.05

449

2713

Diabetes medication

2308

10716

1.27

23.37

1.5

1.9

0.26

0.23

g/l

44.58

2207

10219

Other and unspecified visual disturbances

264

1363

1.99

23.37

2.0

1.7

0.24

0.23

g/l

0.11

258

1296

Endometriosis of pelvic peritoneum

410

2190

1.74

23.36

1.7

1.8

0.23

g/l

0.11

389

2072

Vitamin deficiency, wide

136

537

2.64

23.32

2.4

1.7

0.21

0.23

g/l

1.49

127

508

Vitamin deficiency

136

537

2.64

23.32

2.4

1.7

0.21

0.23

g/l

1.49

127

508

Insomnia

2027

11082

1.28

23.29

1.7

1.8

0.23

g/l

0.33

1945

10571

Dental operations

1184

4393

1.40

23.28

1.7

1.6

0.24

g/l

0.05

1124

4174

Special screening examination for other diseases and disorders

245

1231

2.03

23.17

1.7

1.5

0.25

0.24

g/l

2.19

235

1177

Diseases of peritoneum

233

1159

2.07

22.91

1.8

1.7

0.24

g/l

0.44

224

1106

Extrapyramidal and movement disorders

789

5423

1.47

22.89

1.7

0.23

g/l

1.01

752

5138

Cholelithiasis, broad definition with cholecystitis

1872

9715

1.29

22.74

1.8

1.7

0.25

0.23

g/l

8.02

1781

9266

Persons with potential health hazards related to communicable diseases

896

6256

1.44

22.74

2.2

1.9

0.24

0.23

g/l

2.03

859

6016

Diseases of inner ear

1133

7933

1.38

22.73

1.7

0.24

g/l

0.13

1090

7543

Diseases of external ear

765

5236

1.48

22.72

1.7

0.24

0.23

g/l

1.59

728

4998

Type 1 diabetes, wide definition

480

2967

1.64

22.62

1.5

1.8

0.24

0.22

g/l

4.50

452

2834

Other disorders of bladder

245

1246

2.01

22.55

3.8

1.5

0.23

0.24

g/l

0.91

232

1193

768

4723

1.48

22.50

1.7

1.5

0.23

0.24

g/l

3.25

722

4474

Lichen planus

294

1592

1.89

22.49

1.7

1.6

0.23

0.24

g/l

0.68

282

1515

Intestinal malabsorption

133

530

2.62

22.43

1.5

1.8

0.22

0.24

g/l

0.93

127

507

Disorder of lipoprotein metabolism, unspecified

249

1275

1.99

22.43

1.6

1.5

0.26

0.23

g/l

4.90

237

1224

Need for other prophylactic measures

153

650

2.45

22.43

1.9

1.6

0.25

0.24

g/l

0.90

146

619

Caries of dentine, including avohilmo

1610

6262

1.32

22.41

1.8

1.7

0.23

g/l

0.15

1541

5959

Fracture of lumbar spine and pelvis

450

2742

1.66

22.31

1.9

1.6

0.23

0.24

g/l

0.41

429

2585

Lichen planus, including avohilmo

424

2556

1.69

22.27

1.7

0.23

0.24

g/l

0.43

404

2429

Other epidermal thickening

121

462

2.73

22.21

2.2

1.5

0.24

g/l

0.02

114

441

Other disorders of pigmentation

124

480

2.69

22.17

1.6

0.23

0.24

g/l

0.12

112

454

Persistent mood disorders

425

2567

1.69

22.10

1.8

0.24

0.23

g/l

0.23

396

2453

Restless leg syndrome

343

1957

1.79

22.09

1.8

0.23

g/l

0.35

331

1860

Crohn's disease of large intestine

144

600

2.50

22.07

1.8

0.24

0.23

g/l

0.12

135

571

Hyperkinetic disorders

369

2094

1.76

22.03

1.7

2.0

0.22

g/l

0.45

352

2012

Acute pancreatitis

395

2348

1.71

21.80

1.8

1.7

0.25

0.23

g/l

2.13

382

2235

Arterial embolism and thrombosis

124

482

2.65

21.80

1.5

0.25

0.24

g/l

0.45

117

460

Caries of enamel

2165

11299

1.26

21.76

1.9

1.8

0.23

g/l

0.41

2072

10796

Spirochaetal infections, other/unspecified

217

1074

2.08

21.73

1.9

1.7

0.22

0.24

g/l

1.72

198

1024

Other noninfective disorders of lymphatic vessels and lymph nodes

112

417

2.82

21.71

1.8

1.7

0.24

g/l

0.27

106

393

Cholelithiasis

1795

9584

1.29

21.39

1.8

1.7

0.25

0.23

g/l

7.79

1707

9137

Excessive attrition of teeth

1394

10525

1.32

21.27

1.9

1.8

0.23

g/l

2.27

1345

10051

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

538

3021

1.58

21.03

1.8

2.0

0.22

0.23

g/l

1.35

517

2909

Acetic acid derivatives and related substances

508

1626

1.63

20.99

1.5

1.9

0.23

g/l

0.10

483

1550

Elevated blood glucose level

195

940

2.13

20.93

1.5

1.6

0.25

0.23

g/l

1.64

187

894

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

599

3918

1.53

20.89

1.7

2.0

0.23

g/l

0.18

558

3754

Hydronephrosis

223

1129

2.02

20.81

1.4

1.6

0.26

0.23

g/l

3.49

218

1072

Suppurative and necrotic conditions of lower respiratory tract

132

543

2.52

20.75

1.9

1.5

0.24

g/l

0.16

123

521

Other/unspecified enthesopathies, not elsewhere classified

181

850

2.18

20.74

1.8

1.6

0.24

g/l

0.07

175

802

Atypical facial pain

142

605

2.44

20.74

1.7

1.9

0.22

0.23

g/l

0.82

131

579

Ethmoidectomy

304

1708

1.82

20.68

1.8

0.23

0.24

g/l

0.30

294

1628

Meningitis

135

563

2.50

20.68

3.0

1.6

0.22

0.24

g/l

1.22

125

535

Infections with a predominantly sexual mode of transmission, including avohilmo

944

6238

1.40

20.55

2.3

1.9

0.22

0.23

g/l

1.76

894

5997

Gingivitis and periodontal diseases

2102

8651

1.26

20.47

1.8

1.7

0.24

0.23

g/l

0.70

2002

8249

Other and unspecified nerve root and plexus disorders, also in other diseases

446

2781

1.63

20.47

1.6

1.7

0.24

g/l

0.22

417

2653

Visual field defects

190

917

2.13

20.35

2.0

1.6

0.23

0.24

g/l

0.46

178

873

FESS (DNB20)

297

1666

1.83

20.33

1.8

0.23

0.24

g/l

0.26

287

1588

KRA_PSY_EATING, excluding more controls

216

1082

2.03

20.29

2.0

2.1

0.22

g/l

0.13

209

1039

Other disorders of ear

1975

10156

1.26

20.27

1.7

0.23

0.24

g/l

1.36

1874

9701

Viral pneumonia (known virus, not influenza)

299

3.11

20.25

2.5

1.4

0.24

g/l

0.17

286

Postzoster neuralgia

156

4.07

20.21

1.7

1.6

0.22

0.23

g/l

0.18

151

Lung cancer and mesothelioma

276

1270

1.87

20.20

1.4

0.24

g/l

0.22

260

1197

Unspecified/other endometriosis

251

1311

1.92

20.17

1.8

2.0

0.24

0.23

g/l

1.10

233

1241

Varicose veins

1204

6809

1.35

20.17

1.8

1.7

0.23

0.24

g/l

2.30

1154

6467

Tonsillectomy and adenotomy

1320

6962

1.33

20.14

1.9

0.23

g/l

2.02

1265

6681

Other disorders of eyelid

854

5747

1.42

20.06

1.7

1.6

0.23

0.24

g/l

0.30

819

5443

Pneumococcal septicemia

101

372

2.85

20.04

3.3

1.4

0.23

0.24

g/l

0.30

354

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

475

3026

1.60

20.02

2.1

2.0

0.22

0.23

g/l

1.27

457

2906

Speech therapy

541

3551

1.55

19.86

2.0

1.7

0.24

g/l

0.12

514

3375

Left ventricular outflow tract obstruction (LVOTO), broad definition

236

1242

1.95

19.83

2.2

1.6

0.24

g/l

0.06

219

1193

Non-follicular lymphoma

197

973

2.08

19.82

1.7

1.5

0.22

0.24

g/l

1.87

179

928

Synovial cyst of popliteal space [Baker]

157

710

2.27

19.81

1.5

1.6

0.24

g/l

0.28

151

667

Tongue abnormality

155

700

2.30

19.77

2.3

1.6

0.24

g/l

0.01

146

669

Ganglion

430

2680

1.63

19.74

1.5

1.8

0.24

0.23

g/l

0.76

410

2554

Cluster headache, wide,, including avohilmo

152

682

2.32

19.74

1.8

1.9

0.23

g/l

0.20

147

642

Type of accident

630

4272

1.49

19.73

2.0

1.8

0.23

g/l

0.04

598

4069

Cluster headache, strict, including avohilmo

147

653

2.34

19.57

1.8

1.9

0.23

g/l

0.14

142

613

Postmenopausal osteoporosis with pathological fracture

149

664

2.32

19.57

2.0

1.5

0.22

0.23

g/l

0.35

140

626

Other acute skin changes due to ultraviolet radiation

343

2.90

19.54

2.2

1.6

0.23

0.24

g/l

0.78

332

Acute peritonitis

145

640

2.34

19.46

2.0

1.5

0.24

g/l

0.12

140

613

Chorioretinal inflammation

306

3.03

19.45

2.1

1.7

0.23

0.24

g/l

0.43

293

Other sleep disorders

245

1312

1.91

19.43

1.9

1.7

0.23

g/l

0.06

234

1251

Benign paroxysmal vertigo

612

4141

1.50

19.40

1.7

0.24

0.23

g/l

1.03

590

3914

Aortic valve malfunction, age under 60 years

218

1128

1.99

19.29

2.2

1.6

0.24

g/l

0.16

203

1083

Pain associated with micturition

276

1540

1.83

19.23

2.2

1.7

0.23

g/l

0.37

260

1460

Other or unspecified ileus, impaction or obstruction

342

2023

1.72

19.22

1.4

1.6

0.24

g/l

0.38

326

1916

Sub-endpoint used in defining T1D endpoints

584

3854

1.51

19.20

1.6

1.7

0.24

0.23

g/l

2.99

552

3683

Panic disorder

352

2104

1.70

19.17

1.7

1.9

0.23

g/l

0.47

333

2020

Carrier of infectious disease

310

3.01

19.10

2.2

1.7

0.24

g/l

0.23

294

Cardiodefibrillation

626

4253

1.49

19.08

1.7

1.5

0.24

g/l

0.19

600

4030

Chronic pancreatitis

258

1414

1.86

19.05

1.4

1.6

0.24

g/l

0.36

244

1350

Intracranial injury

1228

8702

1.33

19.04

1.8

1.7

0.24

0.23

g/l

0.74

1170

8306

Other demyelinating diseases of the central nervous system

119

489

2.55

18.98

1.7

1.8

0.23

g/l

0.08

114

461

Ankylosing spondylitis, ICD10

211

1087

2.00

18.93

1.6

1.7

0.23

0.24

g/l

0.39

201

1037

Benign neoplasm: Colon, unspecified

485

3141

1.57

18.93

1.7

1.6

0.24

g/l

0.23

461

2980

Retinal detachments and breaks

680

4716

1.46

18.93

1.6

0.24

g/l

0.02

655

4472

Injuries to the hip and thigh

958

6298

1.38

18.92

1.8

1.6

0.24

0.23

g/l

0.41

914

5992

Other female pelvic inflammatory diseases

374

2282

1.67

18.91

1.9

0.23

g/l

0.73

350

2170

Disorders of continuity of bone

243

1313

1.90

18.84

2.1

1.7

0.22

0.23

g/l

1.08

232

1250

Other and unspecified follicular disorders

116

473

2.56

18.72

1.5

1.8

0.23

0.24

g/l

0.57

110

449

Aortic aneurysm

378

2272

1.65

18.47

1.5

0.24

g/l

0.15

360

2163

Injuries to the neck

518

3425

1.54

18.43

1.7

1.9

0.24

0.23

g/l

0.56

497

3280

Other disorders of the musculoskeletal system and connective tissue

316

1866

1.73

18.08

1.5

1.7

0.24

g/l

0.64

303

1775

Decubitus ulcer and pressure area

124

528

2.41

18.04

1.8

1.4

0.25

0.24

g/l

0.73

114

506

Other and unspecified diseases of blood and blood-forming organs

276

3.06

17.98

2.4

1.7

0.25

0.24

g/l

0.50

266

Invasive ventilation

166

803

2.13

17.77

1.6

1.5

0.24

g/l

0.82

152

768

Nasal polyp

366

2256

1.65

17.67

1.5

1.7

0.23

0.24

g/l

0.08

354

2153

Spontaneous rupture of synovium and tendon

166

804

2.11

17.62

1.8

1.5

0.23

0.24

g/l

0.20

159

754

Autoimmune hyperthyroidism

122

523

2.39

17.48

1.6

1.3

0.23

0.24

g/l

0.72

114

499

Menorrhagia

742

2913

1.44

17.40

2.0

1.8

0.23

g/l

0.67

700

2766

Other disorders of conjunctiva

292

1706

1.75

17.37

1.8

1.6

0.23

0.24

g/l

0.33

277

1621

Dental pulpitis, including avohilmo

2045

10652

1.24

17.34

1.7

1.8

0.24

0.23

g/l

1.69

1960

10191

Phobic anxiety disorders

312

1853

1.71

17.29

1.7

2.0

0.23

g/l

0.57

304

1775

Hereditary angioödema type 1

45.86

17.29

3.2

1.4

0.14

0.25

g/l

—

Disorders of optic nerve and visual pathways

233

1279

1.87

17.27

2.1

1.8

0.23

g/l

0.44

223

1212

Barrett oesophagus

116

491

2.44

17.22

1.8

1.4

0.24

g/l

0.09

107

464

Acute pancreatitis (for exclusion)

395

2499

1.61

17.15

1.8

1.6

0.25

0.24

g/l

1.44

382

2382

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

181

916

2.03

17.15

1.9

1.8

0.25

0.23

g/l

2.03

171

877

Other diseases of pancreas

183

929

2.02

17.15

1.9

1.6

0.23

0.24

g/l

0.71

173

885

Lateral epicondylitis

270

1550

1.77

17.08

1.7

1.8

0.24

g/l

0.09

261

1469

Other disorders of nervous system

156

752

2.14

16.90

1.5

1.6

0.24

g/l

0.03

144

718

Intestinal stricture

585

4032

1.47

16.90

1.6

0.23

0.24

g/l

0.21

552

3830

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

660

4600

1.44

16.88

2.1

2.0

0.23

g/l

0.24

631

4414

Scoliosis

197

1031

1.96

16.88

1.8

1.9

0.23

g/l

0.04

188

983

Secondary and unspecified malignant neoplasm of lymph nodes

180

914

2.02

16.85

1.5

1.6

0.24

0.23

g/l

0.36

168

869

Inflammatory disease of uterus

350

2165

1.65

16.83

2.1

0.23

g/l

0.14

324

2069

Superficial injury of wrist and hand

470

3109

1.53

16.74

1.6

1.8

0.23

g/l

0.54

449

2971

COPD, hospital admissions 1, only main diagnosis

585

3457

1.47

16.70

1.5

0.24

g/l

0.70

559

3279

Unstable angina pectoris

595

3216

1.47

16.68

1.8

1.5

0.25

0.23

g/l

2.09

559

3039

Thoracic aortic aneurysm

260

1487

1.78

16.67

1.4

1.5

0.24

g/l

0.06

246

1421

Oesophageal varices

396

2.60

16.65

1.4

1.6

0.20

0.24

g/l

4.07

377

Disorders of refraction and accommodation

643

4509

1.44

16.62

2.0

1.9

0.23

g/l

0.57

604

4321

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

655

4634

1.43

16.49

1.4

1.8

0.27

0.23

g/l

25.51

628

4430

Glucagon-like peptide-1 (GLP-1) analogues

655

4634

1.43

16.49

1.4

1.8

0.27

0.23

g/l

25.51

628

4430

Delirium, not induced by alcohol and other psychoactive substances

228

1255

1.84

16.47

1.8

1.5

0.22

0.24

g/l

1.49

215

1184

Benign thyroid growths and nodules

655

4299

1.43

16.43

1.7

0.24

0.23

g/l

0.26

619

4073

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

873

6393

1.36

16.37

2.0

1.9

0.24

0.23

g/l

0.80

843

6144

Diabetic retinopathy

710

3127

1.43

16.35

1.4

1.6

0.26

0.25

g/l

1.03

679

2999

Multiple myeloma

252

3.03

16.35

1.6

1.7

0.24

0.22

g/l

0.60

240

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

252

3.03

16.35

1.6

1.7

0.24

0.22

g/l

0.60

240

Otitis media, unspecified

264

1402

1.77

16.29

1.8

1.9

0.22

g/l

0.37

251

1344

Benign neoplasm: Stomach

210

1139

1.89

16.18

1.7

1.6

0.24

g/l

0.19

198

1086

Viral meningitis, including avohilmo

108

457

2.46

16.18

3.0

1.8

0.22

0.24

g/l

0.99

102

430

Otitis externa

497

3351

1.50

16.17

1.9

1.8

0.24

0.23

g/l

1.27

475

3193

Acne

261

1502

1.76

16.12

2.3

2.1

0.22

g/l

0.14

245

1439

Superficial injury of head

499

3363

1.50

16.12

1.7

1.8

0.23

g/l

0.39

477

3197

Transport accidents

967

6051

1.34

16.12

1.9

1.8

0.24

0.23

g/l

1.21

924

5815

Otitis externa, unspecified

268

1564

1.75

16.11

1.8

0.24

0.23

g/l

1.16

256

1493

Fibroblastic disorders

403

2598

1.57

16.09

1.7

1.6

0.23

0.24

g/l

0.37

385

2451

Viral meningitis

104

434

2.50

16.07

3.1

1.8

0.22

0.24

g/l

0.95

410

Childhood allergy (age < 16)

341

1733

1.65

16.07

1.8

2.1

0.22

g/l

0.00

327

1675

Hypopituitarism

171

869

2.02

16.02

2.0

1.6

0.24

g/l

0.09

165

832

Other keratitis

258

1494

1.76

15.93

2.2

1.9

0.24

0.23

g/l

0.73

245

1421

Chondrocostal junction syndrome [Tietze]

105

442

2.48

15.91

1.5

1.7

0.24

g/l

0.22

424

Diabetic retinopathy, strict definition

367

2059

1.61

15.90

1.3

1.6

0.26

g/l

0.72

352

1975

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

383

2382

1.59

15.81

1.7

1.8

0.24

0.23

g/l

0.80

374

2273

Cholecystectomy

1470

9943

1.26

15.78

1.8

1.7

0.25

0.23

g/l

6.15

1401

9480

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

192

1003

1.93

15.75

2.8

1.8

0.22

g/l

0.04

184

955

Ascites

154

758

2.08

15.74

2.0

1.6

0.22

0.24

g/l

2.02

144

728

Other and unspecified disorders of vitreous body

842

6112

1.36

15.73

1.7

0.23

0.24

g/l

1.45

798

5818

Plantar fascial fibromatosis

206

1120

1.88

15.70

2.0

1.7

0.23

g/l

0.59

195

1060

Diabetic neuropathy

244

1391

1.79

15.69

1.3

1.5

0.26

g/l

0.32

234

1330

Substance use, excluding alcohol

423

2778

1.55

15.63

1.9

1.8

0.24

0.23

g/l

1.17

405

2663

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

363

2234

1.60

15.59

1.7

1.8

0.24

0.23

g/l

0.79

355

2132

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

107

459

2.43

15.56

2.3

1.5

0.23

g/l

0.09

101

440

conjunctival haemorrhage

164

831

2.03

15.51

1.8

1.6

0.23

0.24

g/l

0.93

155

796

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

385

2482

1.58

15.51

1.5

1.8

0.23

g/l

0.98

363

2373

Thyroiditis

183

965

1.95

15.48

1.9

0.23

g/l

0.31

174

915

Ulcerative colitis (strict definition, require KELA)

361

2297

1.60

15.41

1.6

1.8

0.22

0.23

g/l

1.28

339

2193

Mental and behavioural disorders due to psychoactive substance use

1182

8434

1.29

15.39

1.7

0.24

g/l

1.72

1124

8093

Substance abuse

1147

8273

1.30

15.37

1.7

0.24

g/l

2.11

1090

7937

Dislocation, sprain and strain of joints and ligaments at neck level

359

2286

1.60

15.31

1.6

1.9

0.24

0.23

g/l

1.52

346

2187

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

638

4554

1.42

15.29

1.8

0.24

0.23

g/l

0.32

608

4368

Amenorrhoea

182

962

1.94

15.24

2.4

2.0

0.22

g/l

0.50

174

914

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

352

2233

1.60

15.23

1.6

1.8

0.22

0.23

g/l

1.09

330

2131

Lung diseases due to external agents

246

1423

1.76

15.17

1.8

1.5

0.24

g/l

0.07

236

1357

Actinic keratosis

656

4273

1.41

15.15

1.7

1.5

0.22

0.24

g/l

3.50

617

4044

Dermatophytosis, including avohilmo

1368

10671

1.26

15.04

1.8

1.7

0.23

0.24

g/l

1.24

1315

10189

Non-Hodgkin lymphoma, all

385

2.52

15.02

1.6

0.21

0.23

g/l

1.27

366

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

369

2373

1.58

15.02

1.8

1.7

0.23

g/l

0.01

354

2254

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1050

7013

1.31

14.96

2.1

2.0

0.23

g/l

1.12

1009

6692

Skin changes due to chronic exposure to nonionizing radiation

676

4417

1.40

14.90

1.7

1.5

0.23

0.24

g/l

3.16

634

4181

Cardiac arrest

104

373

2.41

14.89

1.2

1.5

0.25

0.23

g/l

1.20

353

Olecranon bursitis

117

529

2.27

14.89

1.9

1.5

0.24

g/l

0.38

111

502

Thyrotoxicosis

536

3735

1.45

14.76

1.8

0.23

g/l

0.32

506

3548

Speech disturbances, not elsewhere classified

180

957

1.92

14.75

1.8

1.6

0.24

g/l

0.03

168

909

Thyrotoxicosis, other and/or unspecified

423

2814

1.53

14.75

1.7

1.8

0.23

g/l

0.07

400

2681

Procreative management

738

4452

1.38

14.73

1.9

1.8

0.23

g/l

0.07

692

4276

Extreme obesity with alveolar hypoventilation

101

433

2.42

14.69

1.4

1.7

0.26

0.24

g/l

1.55

413

Overexertion and strenuous or repetitive movements

221

1255

1.80

14.68

1.7

0.25

0.24

g/l

1.21

213

1198

Anogenital herpesviral [herpes simplex] infection

170

891

1.96

14.67

2.5

2.1

0.21

0.23

g/l

1.45

163

846

Retinal vascular occlusion

215

1211

1.81

14.60

1.5

0.24

g/l

0.14

208

1144

Open wound of ankle and foot

222

1265

1.79

14.54

1.8

1.6

0.24

g/l

0.01

208

1206

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

237

2.99

14.52

2.6

1.5

0.22

0.24

g/l

0.55

229

Pyothorax

100

430

2.41

14.42

2.1

1.4

0.24

g/l

0.13

413

Oral lichen planus, including avohilmo , including avohilmo

168

883

1.96

14.38

1.7

1.8

0.23

0.24

g/l

0.83

161

840

Arthropathy in ulcerative colitis

161

3.49

14.25

2.1

1.4

0.22

0.24

g/l

1.18

156

Colonic or urogenital fistula

535

3755

1.44

14.17

2.0

1.7

0.24

g/l

0.40

507

3584

Chondropathies

328

2084

1.60

14.16

1.9

0.24

0.23

g/l

0.18

310

1984

Degeneration of macula and posterior pole

834

4825

1.34

14.11

1.8

1.5

0.23

0.24

g/l

0.77

786

4563

Other condition

312

1961

1.62

14.10

1.9

1.8

0.24

g/l

0.02

297

1872

Fracture of foot, except ankle

533

3743

1.44

14.08

1.9

1.8

0.23

g/l

0.23

506

3588

Retinal vascular disorders

215

1225

1.79

14.05

1.5

0.24

g/l

0.12

208

1158

Faecal incontinence

188

1032

1.86

13.97

2.2

1.7

0.22

0.23

g/l

1.16

172

985

Personality disorders

587

4201

1.41

13.94

1.8

1.9

0.24

0.23

g/l

0.57

554

4043

Impetigo

121

572

2.19

13.92

2.6

1.7

0.22

0.23

g/l

0.64

111

542

Insulin, fast-acting (human)

293

1819

1.64

13.91

1.5

1.8

0.24

0.23

g/l

1.23

278

1732

Other noninflammatory disorders of vagina

188

1035

1.86

13.90

2.9

1.8

0.23

g/l

0.47

178

978

Hernia of abdominal wall

875

6660

1.33

13.88

1.5

1.7

0.24

g/l

1.19

820

6363

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Complement C4 [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS